KR101837049B1 - An electroluminescent compound and an electroluminescent device comprising the same - Google Patents

An electroluminescent compound and an electroluminescent device comprising the same Download PDF

Info

Publication number
KR101837049B1
KR101837049B1 KR1020140156829A KR20140156829A KR101837049B1 KR 101837049 B1 KR101837049 B1 KR 101837049B1 KR 1020140156829 A KR1020140156829 A KR 1020140156829A KR 20140156829 A KR20140156829 A KR 20140156829A KR 101837049 B1 KR101837049 B1 KR 101837049B1
Authority
KR
South Korea
Prior art keywords
group
mol
carbon atoms
synthesis
substituted
Prior art date
Application number
KR1020140156829A
Other languages
Korean (ko)
Other versions
KR20160056522A (en
Inventor
현서용
정성욱
김동원
Original Assignee
(주)피엔에이치테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)피엔에이치테크 filed Critical (주)피엔에이치테크
Priority to KR1020140156829A priority Critical patent/KR101837049B1/en
Publication of KR20160056522A publication Critical patent/KR20160056522A/en
Application granted granted Critical
Publication of KR101837049B1 publication Critical patent/KR101837049B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • HELECTRICITY
    • H05ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05BELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00Electroluminescent light sources
    • H05B33/12Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • H10K85/622Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/653Aromatic compounds comprising a hetero atom comprising only oxygen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/655Aromatic compounds comprising a hetero atom comprising only sulfur as heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1014Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S428/00Stock material or miscellaneous articles
    • Y10S428/917Electroluminescent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

본 발명은 유기전계발광소자에 채용되는 유기발광 화합물에 관한 것으로서, 하기 [화학식 1]로 표시되고, 이를 발광층 내의 도판트 화합물로 채용하는 경우 구동전압, 휘도 및 장수명 등의 발광특성이 우수한 유기전계발광소자를 구현할 수 있다.
[화학식 1]

Figure 112014108723257-pat00153
The present invention relates to an organic electroluminescent compound used in an organic electroluminescent device, and is represented by the following formula (1), and when it is employed as a dopant compound in a light emitting layer, an organic electroluminescent A light emitting element can be realized.
[Chemical Formula 1]
Figure 112014108723257-pat00153

Description

유기발광 화합물 및 이를 포함하는 유기전계발광소자{An electroluminescent compound and an electroluminescent device comprising the same}TECHNICAL FIELD The present invention relates to an organic electroluminescent compound and an electroluminescent device comprising the same,

본 발명은 유기발광 화합물에 관한 것으로서, 보다 구체적으로는 유기전계발광소자의 발광층에 도판트 화합물로 채용되는 유기발광 화합물 및 이를 채용하여 장수명 및 발광 효율이 현저히 향상된 유기전계발광소자에 관한 것이다.More particularly, the present invention relates to an organic light emitting compound which is used as a dopant compound in a light emitting layer of an organic electroluminescent device, and an organic electroluminescent device which has a remarkably improved longevity and luminous efficiency by employing the same.

유기발광 현상이란 유기 물질을 이용하여 전기에너지를 빛에너지로 전환시켜주는 현상을 말한다. 유기발광 현상을 이용하는 유기전계발광소자는 통상 양극과 음극 및 이 사이에 유기물층을 포함하는 구조를 가진다. 여기서 유기물층은 유기전계발광소자의 효율과 안정성을 높이기 위하여 각기 다른 물질로 구성된 다층의 구조로 이루어진 경우가 많으며, 예컨대 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등으로 이루어질 수 있다. 이러한 유기전계발광소자의 구조에서 두 전극 사이에 전압을 걸어주게 되면 양극에서는 정공이, 음극에서는 전자가 유기물층에 주입되게 되고, 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 다시 바닥상태로 떨어질 때 빛이 나게 된다. 이러한 유기전계발광소자는 자발광, 고휘도, 고효율, 낮은 구동 전압, 넓은 시야각, 높은 콘트라스트, 고속 응답성 등의 특성을 갖는 것으로 알려져 있다.An organic light emitting phenomenon is a phenomenon that converts electric energy into light energy by using an organic material. An organic electroluminescent device using an organic light emitting phenomenon usually has a structure including an anode, an anode, and an organic material layer therebetween. Here, in order to enhance the efficiency and stability of the organic electroluminescent device, the organic material layer may have a multi-layer structure composed of different materials and may include a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer. When a voltage is applied between the two electrodes in the structure of such an organic electroluminescent device, holes are injected into the anode, electrons are injected into the organic layer from the cathode, excitons are formed when injected holes and electrons meet, When it falls back to the ground state, the light comes out. Such an organic electroluminescent device is known to have properties such as self-emission, high luminance, high efficiency, low driving voltage, wide viewing angle, high contrast, and high speed response.

유기전계발광소자에서 유기물층으로 사용되는 물질은 기능에 따라, 발광 물질과 전하 수송 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. 또한, 발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과 보다 나은 천연색을 구현하기 위해 필요한 노란색 및 주황색 발광 물질로 구분될 수 있다.Materials used as an organic material layer in an organic electroluminescent device can be classified into a light emitting material and a charge transporting material, a hole injecting material, a hole transporting material, an electron transporting material, and an electron injecting material depending on functions. In addition, the luminescent material can be classified into blue, green and red luminescent materials and yellow and orange luminescent materials necessary for realizing a better natural color depending on the luminescent color.

한편, 발광 물질로서 하나의 물질만 사용하는 경우 분자간 상호 작용에 의하여 최대 발광 파장이 장파장으로 이동하고 색순도가 떨어지거나 발광 감쇄 효과로 소자의 효율이 감소되는 문제가 발생하므로, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여 발광 물질로서 호스트/도판트 계를 사용할 수 있다.On the other hand, when only one material is used as the light emitting material, there arises a problem that the maximum light emitting wavelength shifts to a long wavelength due to intermolecular interaction, the color purity drops, or the efficiency of the device decreases due to the light emission attenuating effect. A host / dopant system may be used as a light emitting material in order to increase the efficiency of light emission through the light emitting layer.

유기 발광 소자가 전술한 우수한 특징들을 충분히 발휘하기 위해서는 소자 내 유기물층을 이루는 물질, 예컨대 정공 주입 물질, 정공 수송 물질, 발광 물질, 전자 수송 물질, 전자 주입 물질 등이 안정하고 효율적인 재료에 의하여 뒷받침되는 것이 선행되어야 하나, 아직까지 안정하고 효율적인 유기 발광 소자용 유기물층 재료의 개발이 충분히 이루어지지 않은 상태이다. 따라서 새로운 재료의 개발이 계속 요구되고 있으며, 이와 같은 재료 개발의 필요성은 전술한 다른 유기 전자 소자에서도 마찬가지이다.In order for the organic luminescent device to sufficiently exhibit the above-described excellent characteristics, a material constituting the organic material layer in the device, such as a hole injecting material, a hole transporting material, a luminescent material, an electron transporting material and an electron injecting material is supported by a stable and efficient material However, development of a stable and efficient organic material layer material for an organic light emitting device has not been sufficiently developed yet. Therefore, development of new materials is continuously required, and the necessity of developing such materials is the same in other organic electronic devices described above.

청색발광물질로서 미국 등록특허 제US7053255에는 중심부는 디페닐안트라센 구조를 가지며, 아릴기가 말단에 치환된 청색 발광 화합물 및 이를 이용한 유기전계발광소자가 개시되어 있지만 발광효율 및 휘도가 충분하지 않다는 문제점이 있다. 한편, 미국등록특허공보 제US 7233019호, 대한민국공개특허공보 제2006-0006760호에는 치환된 피렌계 화합물을 이용한 유기전계발광소자가 개시되어 있으나, 청색의 색순도가 낮아서 진한 청색(deep blue)의 구현이 어렵기 때문에 천연색의 풀컬러 디스플레이를 구현하는데 문제점이 있다.As a blue light emitting material, US Pat. No. 7053255 discloses a blue light emitting compound having a diphenyl anthracene structure and an aryl group substituted at the terminal thereof, and an organic electroluminescent device using the blue light emitting compound, but has a problem in that the light emitting efficiency and brightness are not sufficient . On the other hand, US Pat. No. 7233019 and Korean Patent Laid-Open Publication No. 2006-0006760 disclose an organic electroluminescent device using a substituted pyrene compound. However, since the color purity of blue is low, a deep blue It is difficult to realize a full-color full-color display.

본 발명은 유기전계발광소자의 발광층에 도판트 화합물로 채용되어 우수한 발광 특성을 구현할 수 있는 신규한 유기발광 화합물 및 이를 포함하는 유기전계발광 소자를 제공하고자 한다.The present invention provides a novel organic light emitting compound which can be used as a dopant compound in a light emitting layer of an organic electroluminescent device to realize excellent light emitting properties and an organic electroluminescent device including the same.

본 발명은 상기 과제를 해결하기 위하여, 하기 [화학식 1]로 표시되는 것을 특징으로 하는 유기발광 화합물 및 이를 포함하는 유기전계발광소자를 제공한다.In order to solve the above-described problems, the present invention provides an organic light-emitting compound represented by the following Chemical Formula 1 and an organic electroluminescent device including the same.

[화학식 1][Chemical Formula 1]

Figure 112014108723257-pat00001
Figure 112014108723257-pat00001

상기 [화학식 1]에 따른 유기발광 화합물의 구체적인 구조 및 치환기에 대해서는 후술한다.The specific structure and substituent of the organic luminescent compound according to the formula 1 will be described later.

본 발명에 따른 유기발광 화합물을 발광층에 채용한 유기전계발광소자는 보다 향상된 발광 효율과 장수명 특성의 구현이 가능하여 이를 채용한 유기전계발광소자는 다양한 디스플레이 소자에 유용하여 사용될 수 있다.The organic electroluminescent device employing the organic electroluminescent compound according to the present invention in the electroluminescent layer can realize a further improved luminous efficiency and long life, and the organic electroluminescent device employing the same can be used for various display devices.

도 1 내지 5는 본 발명의 일 실시예에 따른 유기전계발광소자의 구조를 예시한 단면도이다.
도 6은 본 발명에 따른 유기발광 화합물의 구조를 나타낸 대표도이다.
1 to 5 are cross-sectional views illustrating the structure of an organic electroluminescent device according to an embodiment of the present invention.
6 is a schematic diagram showing the structure of an organic luminescent compound according to the present invention.

이하, 본 발명을 보다 구체적으로 설명한다.Hereinafter, the present invention will be described more specifically.

본 발명은 하기 [화학식 1] 내지 [화학식 3]으로 표시되는 신규한 유기발광 화합물에 관한 것이다.The present invention relates to a novel organic luminescent compound represented by the following formulas (1) to (3).

[화학식 1][Chemical Formula 1]

Figure 112014108723257-pat00002
Figure 112014108723257-pat00002

상기 [화학식 1]에서,In the above formula (1)

R은 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택되는 어느 하나이다.R represents a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted heterocycloalkyl group having 2 to 30 carbon atoms, A substituted or unsubstituted aryl group having 3 to 50 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms substituted or unsubstituted, in which at least one of substituted or unsubstituted C3 to C30 cycloalkyl is fused, And a substituted or unsubstituted C2 to C50 heteroaryl group in which at least one unsubstituted C3 to C30 cycloalkyl is fused.

L은 치환 또는 비치환된 탄소수 1 내지 30의 알킬렌기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐렌기 및 치환 또는 비치환된 탄소수 2 내지 30의 알키닐렌기 중에서 선택되는 어느 하나이며, n은 0 내지 2의 정수이고, 상기 n이 2인 경우 복수의 L은 서로 동일하거나 상이하다.L is a substituted or unsubstituted alkylene group having 1 to 30 carbon atoms, a substituted or unsubstituted group having 2 to 30 carbon atoms An alkenylene group and a substituted or unsubstituted alkynylene group having 2 to 30 carbon atoms, n is an integer of 0 to 2, and when n is 2, a plurality of L's are the same or different from each other.

A1, A2, R1 및 R2는 각각 독립적으로 수소, 중수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 알케닐기, 치환 또는 비치환된 탄소수 2 내지 30의 알키닐기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 30의 시클로알케닐기, 치환 또는 비치환된 탄소수 1 내지 30의 알콕시기, 치환 또는 비치환된 탄소수 6 내지 30의 아릴옥시기, 치환 또는 비치환된 탄소수 1 내지 30의 알킬티옥시기, 치환 또는 비치환된 탄소수 5 내지 30의 아릴티옥시기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기, 치환 또는 비치환된 실릴기, 아미노기, 싸이올기, 시아노기, 히드록시기, 니트로기, 할로겐기 및 하기 [구조식 1]로 표시되는 아민기 중에서 선택되는 어느 하나이다.A 1 , A 2 , R 1 and R 2 are each independently selected from the group consisting of hydrogen, deuterium, a substituted or unsubstituted alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted alkenyl group having 2 to 30 carbon atoms, A substituted or unsubstituted C2-C30 alkynyl group, a substituted or unsubstituted C3-C30 cycloalkyl group, a substituted or unsubstituted C2-C30 heterocycloalkyl group, a substituted or unsubstituted C5-C30 cycloalkenyl group, A substituted or unsubstituted C1-C30 alkoxy group, a substituted or unsubstituted C6-C30 aryloxy group, a substituted or unsubstituted C1-C30 alkylthio group, a substituted or unsubstituted C1-C30 aryl A substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted heteroaryl group having 3 to 50 carbon atoms, a substituted or unsubstituted cycloalkyl having 3 to 30 carbon atoms, A substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted or unsubstituted heteroaryl group having 2 to 50 carbon atoms substituted or unsubstituted with at least one fused cycloalkyl having 3 to 30 carbon atoms, An amino group, a thiol group, a cyano group, a hydroxy group, a nitro group, a halogen group and an amine group represented by the following structural formula 1.

상기 A1, A2, R1 및 R2 중에서 적어도 하나 이상은 하기 [구조식 1]로 표시되는 아민기이다.At least one of A 1 , A 2 , R 1 and R 2 is an amine group represented by the following structural formula (1).

[구조식 1][Structural formula 1]

Figure 112014108723257-pat00003
Figure 112014108723257-pat00003

상기 [구조식 1]에서,In the above formula 1,

Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기, 치환 또는 비치환된 탄소수 2 내지 30의 헤테로시클로알킬기, 치환 또는 비치환된 탄소수 5 내지 50의 아릴기, 치환 또는 비치환된 탄소수 3 내지 50의 헤테로아릴기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬이 하나 이상 융합된 치환 또는 비치환된 탄소수 2 내지 50의 헤테로아릴기 중에서 선택되는 어느 하나이다.Ar 1 and Ar 2 each independently represent a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, a substituted or unsubstituted heterocycloalkyl group having 2 to 30 carbon atoms, a substituted or unsubstituted aryl group having 5 to 50 carbon atoms, a substituted Or a substituted or unsubstituted C3 to C30 heteroaryl group, a substituted or unsubstituted C3 to C30 cycloalkyl substituted or unsubstituted, substituted or unsubstituted C5 to C50 aryl group, and a substituted or unsubstituted C3 to C30 Or a substituted or unsubstituted C2 to C50 heteroaryl group in which at least one of R < 3 > to R < 30 >

상기 R, L, A1, A2, R1 및 R2의 정의에서 "치환 또는 비치환된"의 "치환"은 1종 이상의 치환기로 더 치환되는 것을 의미하는 것으로서, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내지 24의 알케닐기, 탄소수 1 내지 24의 알키닐기, 탄소수 1 내지 24의 헤테로알킬기, 탄소수 6 내지 24의 아릴기, 탄소수 6 내지 24의 아릴알킬기, 탄소수 2 내지 24의 헤테로아릴기, 또는 탄소수 2 내지 24의 헤테로아릴알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 1 내지 24의 알킬아미노기, 탄소수 1 내지 24의 아릴아미노기, 탄소수 1 내지 24의 헤테로아릴아미노기, 탄소수 1 내지 24의 알킬실릴기, 탄소수 1 내지 24의 아릴실릴기 및 탄소수 1 내지 24의 아릴옥시기로 이루어진 군에서 선택되는 것을 특징으로 한다.&Quot; Substituted or unsubstituted ""substituted" in the definition of R, L, A 1 , A 2 , R 1 and R 2 means that one or more substituents are further substituted. A halogen atom, a halogen atom, a hydroxy group, a nitro group, an alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, an alkenyl group having 1 to 24 carbon atoms, an alkynyl group having 1 to 24 carbon atoms, An aryl group having 6 to 24 carbon atoms, an arylalkyl group having 6 to 24 carbon atoms, a heteroaryl group having 2 to 24 carbon atoms, a heteroarylalkyl group having 2 to 24 carbon atoms, an alkoxy group having 24 to 24 carbon atoms, , An alkylamino group having 1 to 24 carbon atoms, a heteroarylamino group having 1 to 24 carbon atoms, an alkylsilyl group having 1 to 24 carbon atoms, an arylsilyl group having 1 to 24 carbon atoms, and an aryloxy group having 1 to 24 carbon atoms And < / RTI >

특히, 상기 [구조식 1]에서의 Ar1 및 Ar2가 각각 독립적으로 1종 이상의 치환기로 더 치환되는 경우, 상기 1종 이상의 치환기는 중수소, 시아노기, 할로겐기, 히드록시기, 니트로기, 탄소수 1 내지 24의 알킬기, 탄소수 1 내지 24의 할로겐화된 알킬기, 탄소수 1 내기 24의 알콕시기, 탄소수 6 내지 24의 아릴기 및 탄소수 2 내지 24의 헤테로아릴기 중에서 선택되는 것을 특징으로 한다.
In particular, when Ar 1 and Ar 2 in the above-mentioned structural formula 1 are each independently substituted with at least one substituent, the at least one substituent may be a group selected from the group consisting of deuterium, cyano, halogen, An alkyl group having 1 to 24 carbon atoms, a halogenated alkyl group having 1 to 24 carbon atoms, an alkoxy group having 1 to 24 carbon atoms, an aryl group having 6 to 24 carbon atoms, and a heteroaryl group having 2 to 24 carbon atoms.

본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물은 하기 [화학식 1-1] 또는 [화학식 1-2]로 표시되는 것일 수 있다.The organic luminescent compound represented by the formula (1) according to the present invention may be represented by the following formula (1-1) or (1-2).

[화학식 1-1] [화학식 1-2][Formula 1-1] [Formula 1-2]

Figure 112014108723257-pat00004
Figure 112014108723257-pat00005
Figure 112014108723257-pat00004
Figure 112014108723257-pat00005

상기 [화학식 1-1] 내지 [화학식 1-2]에서, R, L, n, A1, A2, R1 및 R2는 상기 [화학식 1]에서의 정의와 동일하고, M은 상기 [구조식 1]로 표시되는 아민기다.Wherein R 1, L 2, n, A 1 , A 2 , R 1 and R 2 are the same as defined in the above formula (1) Lt; 1 >

또한, 본 발명의 바람직한 구현예에 의하면, 상기 [화학식 1-1] 내지 [화학식 1-2]에서, 상기 A1, A2, R1 및 R2는 각각 독립적으로 수소, 치환 또는 비치환된 탄소수 1 내지 30의 알킬기, 치환 또는 비치환된 탄소수 3 내지 30의 시클로알킬기 및 치환 또는 비치환된 탄소수 5 내지 50의 아릴기 중에서 선택되는 어느 하나일 수 있다.
According to a preferred embodiment of the present invention, A 1 , A 2 , R 1 and R 2 are each independently selected from the group consisting of hydrogen, substituted or unsubstituted An alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 30 carbon atoms, and a substituted or unsubstituted aryl group having 5 to 50 carbon atoms.

본 발명에 있어서, 상기 치환기들의 예시들에 대해서 아래에서 구체적으로 설명하나, 이에 한정되는 것은 아니다.In the present invention, examples of the substituents will be specifically described below, but the present invention is not limited thereto.

본 발명에 있어서, 상기 알킬기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나 1 내지 50인 것이 바람직하다. 구체적인 예로는 메틸기, 에틸기, 프로필기, n-프로필기, 이소프로필기, 부틸기, n-부틸기, 이소부틸기, tert-부틸기, sec-부틸기, 1-메틸-부틸기, 1-에틸-부틸기, 펜틸기, n-펜틸기, 이소펜틸기, 네오펜틸기, tert-펜틸기, 헥실기, n-헥실기, 1-메틸펜틸기, 2-메틸펜틸기, 4-메틸-2-펜틸기, 3,3-디메틸부틸기, 2-에틸부틸기, 헵틸기, n-헵틸기, 1-메틸헥실기, 시클로펜틸메틸기, 시클로헥틸메틸기, 옥틸기, n-옥틸기, tert-옥틸기, 1-메틸헵틸기, 2-에틸헥실기, 2-프로필펜틸기, n-노닐기, 2,2-디메틸헵틸기, 1-에틸-프로필기, 1,1-디메틸-프로필기, 이소헥실기, 2-메틸펜틸기, 4-메틸헥실기, 5-메틸헥실기 등이 있으나, 이들에 한정되지 않는다.In the present invention, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 50. Specific examples include methyl, ethyl, propyl, n-propyl, isopropyl, butyl, n-butyl, isobutyl, Ethyl, propyl, isopropyl, n-butyl, isobutyl, isobutyl, isobutyl, A tert-butyl group, a tert-butyl group, a 2-pentyl group, a 3,3-dimethylbutyl group, a 2-ethylbutyl group, a heptyl group, Ethylhexyl group, 2-propylpentyl group, n-nonyl group, 2,2-dimethylheptyl group, 1-ethyl-propyl group, 1,1-dimethyl-propyl group , Isohexyl group, 2-methylpentyl group, 4-methylhexyl group, 5-methylhexyl group and the like, but are not limited thereto.

본 발명에 있어서, 알콕시기는 직쇄 또는 분지쇄일 수 있다. 알콕시기의 탄소수는 특별히 한정되지 않으나, 입체적 방해를 주지 않는 범위인 1 내지 30개인 것이 바람직하다. 구체적으로, 메톡시기, 에톡시기, n-프로폭시기, 이소프로폭시기, i-프로필옥시기, n-부톡시기, 이소부톡시기, tert-부톡시기, sec-부톡시기, n-펜틸옥시기, 네오펜틸옥시기, 이소펜틸옥시기, n-헥실옥시기, 3,3-디메틸부틸옥시기, 2-에틸부틸옥시기, n-옥틸옥시기, n-노닐옥시기, n-데실옥시기, 벤질옥시기, p-메틸벤질옥시기 등이 될 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the alkoxy group may be linear or branched. The number of carbon atoms of the alkoxy group is not particularly limited, but is preferably in the range of 1 to 30, which does not cause steric hindrance. Specific examples thereof include a methoxy group, an ethoxy group, an n-propoxy group, an isopropoxy group, an i-propyloxy group, a n-butoxy group, an isobutoxy group, a tert- , Neopentyloxy group, isopentyloxy group, n-hexyloxy group, 3,3-dimethylbutyloxy group, 2-ethylbutyloxy group, n-octyloxy group, n- , A benzyloxy group, a p-methylbenzyloxy group, and the like, but are not limited thereto.

본 발명에 있어서, 상기 알케닐기는 직쇄 또는 분지쇄일 수 있고, 탄소수는 특별히 한정되지 않으나, 2 내지 40인 것이 바람직하다. 구체적인 예로는 비닐기, 1-프로페닐기, 이소프로페닐기, 1-부테닐기, 2-부테닐기, 3-부테닐기, 1-펜테닐기, 2-펜테닐기, 3-펜테닐기, 3-메틸-1-부테닐기, 1,3-부타디에닐기, 알릴기, 1-페닐비닐-1-일기, 2-페닐비닐-1-일기, 2,2-디페닐비닐-1-일기, 2-페닐-2-(나프틸-1-일)비닐-1-일기, 2,2-비스(디페닐-1-일)비닐-1-일기, 스틸베닐기, 스티레닐기 등이 있으나 이들에 한정되지 않는다.In the present invention, the alkenyl group may be straight-chain or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 40. Specific examples include a vinyl group, a 1-propenyl group, an isopropenyl group, a 1-butenyl group, a 2-butenyl group, a 3-butenyl group, a 1-pentenyl group, a 2-pentenyl group, a 3-pentenyl group, 2-phenylvinyl-1-yl group, 2,2-diphenylvinyl-1-yl group, 2-phenyl-2-yl group, But are not limited to, - (naphthyl-1-yl) vinyl-1-yl group, 2,2-bis (diphenyl-1-yl) vinyl-1-yl group, stilbenyl group, styrenyl group and the like.

본 발명에 있어서, 아릴기는 단환식 또는 다환식일 수 있고, 탄소수는 특별히 한정되지 않으나 6 내지 60인 것이 바람직하다. 단환식 아릴기의 예로는 페닐기, 비페닐기, 터페닐기, 스틸벤기 등이 있고, 다환식 아릴기의 예로는 나프틸기, 안트라세닐기, 페난트레닐기, 파이레닐기, 페릴레닐기, 테트라세닐기, 크라이세닐기, 플루오레닐기, 아세나프타센닐기, 트리페닐렌기, 플루오안트렌(fluoranthrene)기 등이 있으나, 본 발명의 범위가 이들 예로만 한정되는 것은 아니다.In the present invention, the aryl group may be monocyclic or polycyclic, and the number of carbon atoms is not particularly limited, but is preferably 6 to 60. [ Examples of the monocyclic aryl group include a phenyl group, a biphenyl group, a terphenyl group and a stilbene group. Examples of the polycyclic aryl group include a naphthyl group, an anthracenyl group, a phenanthrenyl group, a pyrenyl group, a perylenyl group, , A chlorenyl group, a fluorenyl group, an acenaphthacenyl group, a triphenylene group, and a fluororanthrene group, but the scope of the present invention is not limited to these examples.

본 발명에 있어서, 헤테로고리기는 이종원자로 O, N 또는 S를 포함하는 헤테로고리기로서, 탄소수는 특별히 한정되지 않으나 탄소수 2 내지 60인 것이 바람직하다. 헤테로고리기의 예로는 티오펜기, 퓨란기, 피롤기, 이미다졸기, 티아졸기, 옥사졸기, 옥사디아졸기, 트리아졸기, 피리딜기, 비피리딜기, 피리미딜기, 트리아진기, 트리아졸기, 아크리딜기, 피리다진기, 피라지닐기, 퀴놀리닐기, 퀴나졸린기, 퀴녹살리닐기, 프탈라지닐기, 피리도 피리미디닐기, 피리도 피라지닐기, 피라지노 피라지닐기, 이소퀴놀린기, 인돌기, 카바졸기, 벤조옥사졸기, 벤조이미다졸기, 벤조티아졸기, 벤조카바졸기, 벤조티오펜기, 디벤조티오펜기, 벤조퓨라닐기, 디벤조퓨라닐기, 페난트롤린기, 티아졸릴기, 이소옥사졸릴기, 옥사디아졸릴기, 티아디아졸릴기, 벤조티아졸릴기, 페노티아지닐기 등이 있으나, 이들에만 한정되는 것은 아니다.In the present invention, the heterocyclic group is a heterocyclic group containing O, N or S as a heteroatom, and the number of carbon atoms is not particularly limited, but is preferably 2 to 60 carbon atoms. Examples of the heterocyclic group include a thiophene group, a furane group, a furyl group, an imidazole group, a thiazole group, an oxazole group, an oxadiazole group, a triazole group, a pyridyl group, a bipyridyl group, a pyrimidyl group, A pyridazinyl group, a pyrazinopyrazinyl group, an isoquinoline group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolinyl group, an isoquinolyl group, , An indole group, a carbazole group, a benzoxazole group, a benzoimidazole group, a benzothiazole group, a benzocarbazole group, a benzothiophene group, a dibenzothiophene group, a benzofuranyl group, a dibenzofurancyl group, a phenanthroline group, An isothiazolyl group, an isoxazolyl group, an oxadiazolyl group, a thiadiazolyl group, a benzothiazolyl group, a phenothiazinyl group and the like, but is not limited thereto.

본 발명에 있어서, 아릴옥시기, 아릴티옥시기, 아릴술폭시기 및 아랄킬아민기 중의 아릴기는 전술한 아릴기의 예시와 같다. 구체적으로 아릴옥시기로는 페녹시기, p-토릴옥시기, m-토릴옥시기, 3,5-디메틸-페녹시기, 2,4,6-트리메틸페녹시기, ptert-부틸페녹시기, 3-비페닐옥시기, 4-비페닐옥시기, 1-나프틸옥시기, 2-나프틸옥시기, 4-메틸-1-나프틸옥시기, 5-메틸-2-나프틸옥시기, 1-안트릴옥시기, 2-안트릴옥시기, 9-안트릴옥시기, 1-페난트릴옥시기, 3-페난트릴옥시기, 9-페난트릴옥시기 등이 있고, 아릴티옥시기로는 페닐티옥시기기, 2-메틸페닐티옥시기, 4-tert-부틸페닐티옥시기 등이 있으며, 아릴술폭시기로는 벤젠술폭시기, p-톨루엔술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the aryl group in the aryloxy group, arylthioxy group, arylsulfoxy group and aralkylamine group is the same as the aforementioned aryl group. Specific examples of the aryloxy group include a phenoxy group, a p-tolyloxy group, an m-tolyloxy group, a 3,5-dimethyl-phenoxy group, a 2,4,6-trimethylphenoxy group, a ptert- Anthryloxy group, 2-naphthyloxy group, 2-naphthyloxy group, 4-methyl-1-naphthyloxy group, Anthryloxy group, 9-anthryloxy group, 1-phenanthryloxy group, 3-phenanthryloxy group, 9-phenanthryloxy group and the like. Examples of the arylthioxy group include phenylthioxy group, 2- A 4-tert-butylphenyloxy group, and the like. Examples of the arylsulfoxy group include benzene sulfoxy group and p-toluenesulfoxy group. However, the present invention is not limited thereto.

본 발명에 있어서, 시클로알킬기는 특별히 한정되지 않으나, 탄소수 3 내지 60인 것이 바람직하며, 구체적으로 시클로프로필기 시클로부틸기 시클로펜틸기 3-메틸시클로펜틸기 2,3-디메틸시클로펜틸기, 시클로헥실기, 3-메틸시클로헥실기, 4-메틸시클로헥실기, 2,3-디메틸시클로헥실기, 3,4,5-트리메틸시클로헥실기, 4-tert-부틸시클로헥실기, 시클로헵틸기, 시클로옥틸기 등이 있으나, 이에 한정되지 않는다.In the present invention, the cycloalkyl group is not particularly limited, but preferably has 3 to 60 carbon atoms, and specifically includes cyclopropyl group, cyclobutyl group, cyclopentyl group, 3-methylcyclopentyl group, 2,3-dimethylcyclopentyl group, Methylcyclohexyl group, 2,3-dimethylcyclohexyl group, 3,4,5-trimethylcyclohexyl group, 4-tert-butylcyclohexyl group, cycloheptyl group, cyclo An octyl group, and the like, but are not limited thereto.

본 발명에 있어서, 할로겐기의 예로는 불소, 염소, 브롬 또는 요오드가 있다.In the present invention, examples of the halogen group include fluorine, chlorine, bromine or iodine.

본 발명에 있어서, 아릴아민기의 예로는 치환 또는 비치환된 모노아릴아민기, 치환 또는 비치환된 디아릴아민기, 또는 치환 또는 비치환된 트리아릴아민기가 있다. 상기 아릴아민기 중의 아릴기는 단환식 아릴기일 수 있고, 다환식 아릴기일 수 있다. 상기 아릴기가 2 이상을 포함하는 아릴아민기는 단환식 아릴기, 다환식 아릴기, 또는 단환식아릴기와 다환식 아릴기를 동시에 포함할 수 있다.In the present invention, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group having at least two aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or a monocyclic aryl group and a polycyclic aryl group at the same time.

상기 아릴아민기의 구체적인 예로는 페닐아민기, 나프틸아민기, 비페닐아민기, 안트라세닐아민기, 3-메틸-페닐아민기, 4-메틸-나프틸아민기, 2-메틸-비페닐아민기, 9-메틸-안트라세닐아민기, 디페닐 아민기, 페닐 나프틸 아민기, 디톨릴 아민기, 페닐 톨릴 아민기, 카바졸기 및 트리페닐 아민기 등이 있으나, 이에 한정되는 것은 아니다.Specific examples of the arylamine group include a phenylamine group, a naphthylamine group, a biphenylamine group, an anthracenylamine group, a 3-methylphenylamine group, a 4-methylnaphthylamine group, But are not limited to, an amine group, a 9-methyl-anthracenylamine group, a diphenylamine group, a phenylnaphthylamine group, a ditolylamine group, a phenyltolylamine group, a carbazole group and a triphenylamine group.

본 발명에 있어서, 실릴기는 구체적으로 트리메틸실릴기, 트리에틸실릴기, t-부틸디메틸실릴기, 비닐디메틸실릴기, 프로필디메틸실릴기, 트리페닐실릴기, 디페닐실릴기, 페닐실릴기 등이 있으나 이에 한정되지 않는다.In the present invention, the silyl group is specifically exemplified by trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, vinyldimethylsilyl, propyldimethylsilyl, triphenylsilyl, diphenylsilyl, But are not limited thereto.

본 발명에 있어서, 헤테로아릴아민기 중의 헤테로 아릴기는 전술한 헤테로고리기의 예시 중에서 선택될 수 있다.In the present invention, the heteroaryl group in the heteroarylamine group can be selected from the examples of the above-mentioned heterocyclic group.

본 발명에 있어서, 알킬티옥시기, 알킬술폭시기 중의 알킬기는 전술한 알킬기의 예시와 같다. 구체적으로 알킬티옥시기로는 메틸티옥시기, 에틸티옥시기, tert-부틸티옥시기, 헥실티옥시기, 옥틸티옥시기 등이 있고, 알킬술폭시기로는 메실, 에틸술폭시기, 프로필술폭시기, 부틸술폭시기 등이 있으나, 이에 한정되지 않는다.In the present invention, the alkyloxy group in the alkylthio group and the alkyl group in the alkylsulfoxy group are the same as the aforementioned alkyl groups. Specific examples of the alkyloxy group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group and an octylthio group. Examples of the alkylsulfoxy group include a mesyl group, an ethylsulfoxy group, a propylsulfoxy group, But are not limited thereto.

본 발명에 있어서, 치환된 아릴렌기라 함은, 페닐기, 비페닐기, 나프탈렌기, 플루오레닐기, 파이레닐기, 페난트레닐기, 페릴렌기, 테트라세닐기. 안트라센닐기 등이 다른 치환기로 치환된 것을 의미한다.In the present invention, the substituted arylene group means a phenyl group, a biphenyl group, a naphthalene group, a fluorenyl group, a pyrenyl group, a phenanthrenyl group, a perylene group, a tetracenyl group. Anthracenyl group and the like are substituted with other substituents.

본 발명에 있어서, 치환된 헤테로아릴렌기라 함은, 피리딜기, 티오페닐기, 트리아진기, 퀴놀린기, 페난트롤린기, 이미다졸기, 티아졸기, 옥사졸기, 카바졸기 및 이들의 축합헤테로고리기, 예컨대 벤즈퀴놀린기, 벤즈이미다졸기, 벤즈옥사졸기, 벤즈티아졸기, 벤즈카바졸기, 디벤조티오페닐기, 디벤조퓨란기 등이 다른 치환기로 치환된 것을 의미한다.
In the present invention, the substituted heteroarylene group includes a pyridyl group, a thiophenyl group, a triazine group, a quinoline group, a phenanthroline group, an imidazole group, a thiazole group, an oxazole group, a carbazole group and condensed heterocyclic groups, Such as a benzoquinoline group, a benzimidazole group, a benzoxazole group, a benzothiazole group, a benzzcarbazole group, a dibenzothiophenyl group, a dibenzofurane group and the like are substituted with other substituents.

상기 [화학식 1]로 표시되는 본 발명에 따른 유기발광 화합물은 그 구조적 특이성으로 인하여 유기전계발광소자의 다양한 유기물층에 사용될 수 있고, 바람직하게는 발광층 내의 도판트 화합물로 사용될 수 있다.The organic luminescent compound according to the present invention represented by Formula 1 may be used in various organic layers of organic electroluminescent devices due to its structural specificity, and may be used as a dopant compound in a light emitting layer.

본 발명에 따른 [화학식 1]로 표시되는 발광층의 도판트 화합물로 채용될 수 있는 유기발광 화합물의 구체적인 예로는 하기 화합물들이 있으나, 이들에만 한정되는 것은 아니다.Specific examples of the organic luminescent compound that may be employed as the dopant compound of the light emitting layer represented by Formula 1 according to the present invention include, but are not limited to, the following compounds.

Figure 112014108723257-pat00006
Figure 112014108723257-pat00006

Figure 112014108723257-pat00007
Figure 112014108723257-pat00007

Figure 112014108723257-pat00008
Figure 112014108723257-pat00008

Figure 112014108723257-pat00009
Figure 112014108723257-pat00009

Figure 112014108723257-pat00010
Figure 112014108723257-pat00010

Figure 112014108723257-pat00011
Figure 112014108723257-pat00011

Figure 112014108723257-pat00012
Figure 112014108723257-pat00012

Figure 112014108723257-pat00013
Figure 112014108723257-pat00013

Figure 112014108723257-pat00014
Figure 112014108723257-pat00014

Figure 112014108723257-pat00015
Figure 112014108723257-pat00015

Figure 112014108723257-pat00016
Figure 112014108723257-pat00016

Figure 112014108723257-pat00017
Figure 112014108723257-pat00017

Figure 112014108723257-pat00018
Figure 112014108723257-pat00018

Figure 112014108723257-pat00019
Figure 112014108723257-pat00019

Figure 112014108723257-pat00020
Figure 112014108723257-pat00020

Figure 112014108723257-pat00021
Figure 112014108723257-pat00021

Figure 112014108723257-pat00022
Figure 112014108723257-pat00022

Figure 112014108723257-pat00023
Figure 112014108723257-pat00023

Figure 112014108723257-pat00024
Figure 112014108723257-pat00024

Figure 112014108723257-pat00025
Figure 112014108723257-pat00025

Figure 112014108723257-pat00026
Figure 112014108723257-pat00026

Figure 112014108723257-pat00027
Figure 112014108723257-pat00027

Figure 112014108723257-pat00028
Figure 112014108723257-pat00028

Figure 112014108723257-pat00029
Figure 112014108723257-pat00029

Figure 112014108723257-pat00030
Figure 112014108723257-pat00030

Figure 112014108723257-pat00031
Figure 112014108723257-pat00031

Figure 112014108723257-pat00032
Figure 112014108723257-pat00032

Figure 112014108723257-pat00033
Figure 112014108723257-pat00033

Figure 112014108723257-pat00034
Figure 112014108723257-pat00034

Figure 112014108723257-pat00035
Figure 112014108723257-pat00035

Figure 112014108723257-pat00036
Figure 112014108723257-pat00036

Figure 112014108723257-pat00037
Figure 112014108723257-pat00037

Figure 112014108723257-pat00038
Figure 112014108723257-pat00038

Figure 112014108723257-pat00039
Figure 112014108723257-pat00039

Figure 112014108723257-pat00040

Figure 112014108723257-pat00040

상기와 같은 구조의 코어 구조에 다양한 치환기를 도입함으로써 도입된 치환기의 고유 특성을 갖는 유기발광 화합물을 합성할 수 있다. 예컨대, 유기전계발광소자의 제조시 사용되는 정공 주입층 물질, 정공 수송층 물질 및 전자 수송층 물질에 사용되는 치환기를 상기 구조에 도입함으로써 각 유기물층에서 요구하는 조건들을 충족시키는 물질을 제조할 수 있다.An organic luminescent compound having the intrinsic characteristics of the substituent introduced by introducing various substituents into the core structure having the above structure can be synthesized. For example, a substance that meets the requirements of each organic material layer can be manufactured by introducing a substituent used in a hole injecting layer material, a hole transporting layer material, and an electron transporting layer material used in manufacturing an organic electroluminescent device into the structure.

특히, 본 발명에 따른 [화학식 1]로 표시되는 유기발광 화합물은 상기에서 살펴본 바와 같이, 특징적 코어 구조체에 치환기를 도입하여 유기전계발광소자의 발광층에 채용시 효율, 구동전압, 수명 등에서 우수한 특성을 나타내는 유기전계발광소자의 구현이 가능함을 확인하였다.
In particular, the organic electroluminescent compound represented by Formula 1 according to the present invention has excellent characteristics in terms of efficiency at the time of adoption, driving voltage, and life span in a light emitting layer of an organic electroluminescent device by introducing a substituent into the characteristic core structure, It is confirmed that the organic electroluminescent device can be realized.

본 발명의 화합물은 유기전계발광소자의 통상의 제조방법에 따라 소자에 적용할 수 있다. 본 발명의 하나의 실시예에 따른 유기전계발광소자는 제1 전극과 제2 전극 및 이 사이에 배치된 유기물층을 포함하는 구조로 이루어질 수 있으며, 본 발명에 따른 유기발광 화합물을 소자의 유기물층에 사용한다는 것을 제외하고는 통상의 소자의 제조 방법 및 재료를 사용하여 제조될 수 있다.The compound of the present invention can be applied to a device according to a conventional method of manufacturing an organic electroluminescent device. The organic electroluminescent device according to one embodiment of the present invention may have a structure including a first electrode, a second electrode and an organic material layer disposed therebetween, and the organic electroluminescent compound according to the present invention may be used for an organic material layer And can be manufactured using conventional device manufacturing methods and materials.

본 발명에 따른 유기전계발광소자의 유기물층은 단층 구조로 이루어질 수도 있으나, 2층 이상의 유기물층이 적층된 다층 구조로 이루어질 수 있다. 예컨대, 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자 주입층 등을 포함하는 구조를 가질 수 있다. 그러나, 이에 한정되지 않고 더 적은 수의 유기물층을 포함할 수도 있다.The organic material layer of the organic electroluminescent device according to the present invention may have a single layer structure, but may have a multilayer structure in which two or more organic material layers are stacked. For example, a structure including a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer. However, it is not limited to this and may include a smaller number of organic layers.

따라서, 본 발명의 유기전계발광소자에서, 상기 유기물층은 정공 주입층, 정공 수송층, 전자 수송층, 전자 주입층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 주입 및 전자수송을 동시에 하는 층 및 발광층 중 1층 이상을 포함할 수 있고, 상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 화합물을 포함할 수 있으며, 바람직하게는 본 발명에 따른 유기발광 화합물은 발광층 내 도판트 물질로서 포함될 수 있다.Therefore, in the organic electroluminescent device of the present invention, the organic material layer may be a hole injecting layer, a hole transporting layer, an electron transporting layer, an electron injecting layer, a layer simultaneously injecting and transporting holes, a layer simultaneously performing electron injection and electron transporting, One or more of the above layers may include a compound represented by the above formula (1), and preferably, the organic light emitting compound according to the present invention may be included as a dopant in the light emitting layer. have.

상기 [화학식 1]로 표시되는 화합물을 발광층 내 도판트 물질로서 포함되는 경우에, 도판트의 함량은 통상적으로 호스트 약 100 중량부를 기준으로 하여 약 0.01 내지 약 20 중량부의 범위에서 선택될 수 있다. 또한, [화학식 1]로 구현되는 유기발광 화합물 이외의 도판트 화합물은 물론이고, 다양한 호스트 화합물을 포함할 수도 있으며, 그 함량은 상기와 마찬가지이다.
When the compound represented by Formula 1 is included as a dopant in the light emitting layer, the content of the dopant may be generally selected in the range of about 0.01 to about 20 parts by weight based on about 100 parts by weight of the host. In addition to the dopant compound other than the organic luminescent compound represented by Formula 1, it may contain various host compounds, and the content thereof is the same as that described above.

이와 같은 다층 구조의 유기물층에서 상기 [화학식 1]로 표시되는 화합물은 발광층, 정공 주입/정공 수송과 발광을 동시에 하는 층, 정공 수송과 발광을 동시에 하는 층, 또는 전자 수송과 발광을 동시에 하는 층 등에 포함될 수 있다.In the organic compound layer having such a multilayer structure, the compound represented by the formula (1) may be used in combination with a light emitting layer, a layer that simultaneously transports holes and holes, a layer that simultaneously transports light and emits light, .

예컨대, 본 발명에 따른 유기 전자 소자의 구조는 도 1 내지 5에 예시되어 있다.For example, the structure of an organic electronic device according to the present invention is illustrated in Figs.

도 1에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.1 shows an organic electronic device in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5, an electron transporting layer 6 and a cathode 7 are sequentially laminated on a substrate 1 Structure is illustrated. In this structure, the compound represented by the formula (1) may be included in the hole injection layer (3), the hole transport layer (4), the light emitting layer (5) or the electron transport layer (6).

도 2에는 기판(1) 위에 양극(2), 정공 주입층(3), 정공 수송층(4), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 주입층(3), 정공 수송층(4) 또는 전자 수송층(6)에 포함될 수 있다.2 shows the structure of an organic electronic device in which an anode 2, a hole injecting layer 3, a hole transporting layer 4, a light emitting layer 5 and a cathode 7 are sequentially laminated on a substrate 1. In such a structure, the compound represented by the formula (1) may be included in the hole injection layer (3), the hole transport layer (4), or the electron transport layer (6).

도 3에는 기판(1) 위에 양극(2), 정공 수송층(4), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 정공 수송층(4), 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.3 illustrates the structure of an organic electronic device in which an anode 2, a hole transporting layer 4, a light emitting layer 5, an electron transporting layer 6, and a cathode 7 are sequentially stacked on a substrate 1. In such a structure, the compound represented by the formula (1) may be included in the hole transport layer (4), the light emitting layer (5), or the electron transport layer (6).

도 4에는 기판(1) 위에 양극(2), 발광층(5), 전자 수송층(6) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5) 또는 전자 수송층(6)에 포함될 수 있다.4 illustrates the structure of an organic electronic device in which an anode 2, a light emitting layer 5, an electron transport layer 6, and a cathode 7 are sequentially laminated on a substrate 1. In FIG. In such a structure, the compound represented by the formula (1) may be included in the light-emitting layer (5) or the electron-transporting layer (6).

도 5에는 기판(1) 위에 양극(2), 발광층(5) 및 음극(7)이 순차적으로 적층된 유기 전자 소자의 구조가 예시되어 있다. 이와 같은 구조에 있어서, 상기 [화학식 1]로 표시되는 화합물은 상기 발광층(5)에 포함될 수 있다.
5 illustrates the structure of an organic electronic device in which an anode 2, a light-emitting layer 5, and a cathode 7 are sequentially stacked on a substrate 1. As shown in Fig. In such a structure, the compound represented by the formula (1) may be included in the luminescent layer (5).

예컨대, 본 발명에 따른 유기전계발광소자는 스퍼터링(sputtering)이나 전자빔 증발(e-beam evaporation)과 같은 PVD(physical vapor deposition) 방법을 이용하여, 기판 상에 금속 또는 전도성을 가지는 금속 산화물 또는 이들의 합금을 증착시켜 양극을 형성하고, 그 위에 정공 주입층, 정공 수송층, 발광층, 전자 수송층을 포함하는 유기물층을 형성한 후, 그 위에 음극으로 사용할 수 있는 물질을 증착시킴으로써 제조될 수 있다.For example, the organic electroluminescent device according to the present invention can be manufactured by using a physical vapor deposition (PVD) method such as sputtering or e-beam evaporation to form a metal oxide or a conductive metal oxide on the substrate, An anode is formed by depositing an alloy on the anode, and an organic material layer including a hole injecting layer, a hole transporting layer, a light emitting layer, and an electron transporting layer is formed on the anode, and then a substance usable as a cathode is deposited thereon.

이와 같은 방법 외에도, 기판 상에 음극 물질부터 유기물층, 양극 물질을 차례로 증착시켜 유기전계발광소자를 만들 수도 있다. 상기 유기물층은 정공 주입층, 정공 수송층, 발광층 및 전자 수송층 등을 포함하는 다층 구조일 수도 있으나, 이에 한정되지 않고 단층 구조일 수 있다. 또한, 상기 유기물층은 다양한 고분자 소재를 사용하여 증착법이 아닌 솔벤트 프로세스(solvent process), 예컨대 스핀 코팅, 딥 코팅, 닥터 블레이딩, 스크린 프린팅, 잉크젯 프린팅 또는 열 전사법 등의 방법에 의하여 더 적은 수의 층으로 제조할 수 있다.In addition to such a method, an organic electroluminescent device may be formed by sequentially depositing a cathode material, an organic material layer, and a cathode material on a substrate. The organic material layer may have a multi-layer structure including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer, but is not limited thereto and may have a single layer structure. In addition, the organic material layer may be formed using a variety of polymer materials by a solvent process such as a spin coating process, a dip coating process, a doctor blading process, a screen printing process, an inkjet printing process or a thermal transfer process, Layer.

상기 양극 물질로는 통상 유기물층으로 정공주입이 원활할 수 있도록 일함수가 큰 물질이 바람직하다. 본 발명에서 사용될 수 있는 양극 물질의 구체적인 예로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금, 아연 산화물, 인듐 산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물, ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 및 폴리아닐린과 같은 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the anode material, a material having a large work function is preferably used so that hole injection can be smoothly conducted into the organic material layer. Specific examples of the cathode material that can be used in the present invention include metals such as vanadium, chromium, copper, zinc and gold or alloys thereof, zinc oxide, indium oxide, indium tin oxide (ITO), indium zinc oxide (IZO) metal oxides, ZnO: Al or SnO 2: a combination of a metal and an oxide such as Sb, poly (3-methylthiophene), poly [3,4- (ethylene-1,2-dioxy) thiophene] (PEDT) , Conductive polymers such as polypyrrole and polyaniline, but are not limited thereto.

상기 음극 물질로는 통상 유기물층으로 전자 주입이 용이하도록 일함수가 작은 물질인 것이 바람직하다. 음극 물질의 구체적인 예로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석 및 납과 같은 금속 또는 이들의 합금, LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이들에만 한정되는 것은 아니다.The negative electrode material is preferably a material having a small work function to facilitate electron injection into the organic material layer. Specific examples of the negative electrode material include a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead or an alloy thereof; a multilayer such as LiF / Al or LiO 2 / Structural materials, and the like, but are not limited thereto.

정공 주입 물질로는 낮은 전압에서 양극으로부터 정공을 잘 주입받을 수 있는 물질로서, 정공 주입 물질의 HOMO(highest occupied molecular orbital)가 양극 물질의 일함수와 주변 유기물층의 HOMO 사이인 것이 바람직하다. 정공 주입 물질의 구체적인 예로는 금속 포피린(porphyrine), 올리고티오펜, 아릴아민 계열의 유기물, 헥사니트릴 헥사아자트리페닐렌, 퀴나크리돈(quinacridone) 계열의 유기물, 페릴렌(perylene) 계열의 유기물, 안트라퀴논 및 폴리아닐린과 폴리티오펜 계열의 전도성 고분자 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole injecting material, it is preferable that the highest occupied molecular orbital (HOMO) of the hole injecting material be between the work function of the anode material and the HOMO of the surrounding organic layer. Specific examples of the hole injecting material include metal porphyrine, oligothiophene, arylamine-based organic materials, hexanitrile hexaazatriphenylene, quinacridone-based organic materials, perylene-based organic materials, Anthraquinone, polyaniline and a polythiophene-based conductive polymer, but are not limited thereto.

정공 수송 물질로는 양극이나 정공 주입층으로부터 정공을 수송 받아 발광층으로 옮겨줄 수 있는 물질로 정공에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 아릴아민 계열의 유기물, 전도성 고분자, 및 공액 부분과 비공액 부분이 함께 있는 블록 공중합체 등이 있으나, 이들에만 한정되는 것은 아니다.As the hole transporting material, a material capable of transporting holes from the anode or the hole injection layer to the light emitting layer and having high mobility to holes is suitable. Specific examples include arylamine-based organic materials, conductive polymers, and block copolymers having a conjugated portion and a non-conjugated portion together, but are not limited thereto.

발광 물질로는 정공 수송층과 전자 수송층으로부터 정공과 전자를 각각 수송받아 결합시킴으로써 가시광선 영역의 빛을 낼 수 있는 물질로서, 형광이나 인광에 대한 양자효율이 좋은 물질이 바람직하다. 구체적인 예로는 8-히드록시-퀴놀린 알루미늄 착물(Alq3), 카르바졸 계열 화합물, 이량체화 스티릴(dimerized styryl) 화합물, BAlq, 10-히드록시벤조 퀴놀린-금속 화합물, 벤족사졸, 벤즈티아졸 및 벤즈이미다졸 계열의 화합물, 폴리(p-페닐렌비닐렌)(PPV) 계열의 고분자, 스피로(spiro) 화합물, 폴리플루오렌, 루브렌 등이 있으나, 이들에만 한정되는 것은 아니다.The light emitting material is preferably a material capable of emitting light in the visible light region by transporting and combining holes and electrons from the hole transporting layer and the electron transporting layer, respectively, and having a high quantum efficiency for fluorescence or phosphorescence. Specific examples include 8-hydroxy-quinoline aluminum complex (Alq 3 ), carbazol-based compounds, dimerized styryl compounds, BAlq, 10-hydroxybenzoquinoline-metal compounds, benzoxazole, benzthiazole and A benzimidazole-based compound, a poly (p-phenylene vinylene) (PPV) -based polymer, a spiro compound, polyfluorene, rubrene, and the like.

전자 수송 물질로는 음극으로부터 전자를 잘 주입 받아 발광층으로 옮겨줄 수 있는 물질로서, 전자에 대한 이동성이 큰 물질이 적합하다. 구체적인 예로는 8-히드록시퀴놀린의 Al 착물, Alq3를 포함한 착물, 유기 라디칼 화합물, 히드록시플라본-금속 착물 등이 있으나, 이들에만 한정되는 것은 아니다.
As the electron transporting material, a material capable of transferring electrons from the cathode well into the light emitting layer, which is highly mobile, is suitable. Specific examples thereof include, but are not limited to, an Al complex of 8-hydroxyquinoline, a complex containing Alq 3 , an organic radical compound, and a hydroxyflavone-metal complex.

본 발명에 따른 유기전계발광소자는 사용되는 재료에 따라 전면 발광형, 후면 발광형 또는 양면 발광형일 수 있다.The organic electroluminescent device according to the present invention may be a front emission type, a back emission type, or a both-sided emission type, depending on the material used.

또한, 본 발명에 따른 유기발광 화합물은 유기 태양 전지, 유기 감광체, 유기 트랜지스터 등을 비롯한 유기 전자 소자에서도 유기전계발광소자에 적용되는 것과 유사한 원리로 작용할 수 있다.
In addition, the organic electroluminescent compound according to the present invention can act on a principle similar to that applied to an organic electroluminescent device in an organic electronic device including an organic solar cell, an organophotoreceptor, an organic transistor and the like.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시한다. 그러나, 하기의 실시예는 본 발명을 예시하기 위한 것이며, 이에 의하여 본 발명의 범위가 한정되는 것은 아니다.
Hereinafter, preferred embodiments of the present invention will be described in order to facilitate understanding of the present invention. However, the following examples are intended to illustrate the invention and are not intended to limit the scope of the invention.

실시예Example 1 : 화합물 1의 합성 1: Synthesis of compound 1

(1) (One) 제조예Manufacturing example 1 : 중간체 1-2의 합성 1: Synthesis of intermediate 1-2

Figure 112014108723257-pat00041
Figure 112014108723257-pat00041

pyrene(2.0 g, 0.010 mol)에 chlorobenzene(1.3 g, 0.012 mol), aluminum trichloride(1.4 g, 0.011 mol)에 Dichloro methane 100 mL를 넣고 0 ℃에서 3시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 층분리 후 컬럼정제(n-Hexane : MC)하여 <중간체 1-2>를 1.7 g(수율 63%)수득하였다.(m/z=278)
100 mL of dichloromethane was added to chlorobenzene (1.3 g, 0.012 mol) and aluminum trichloride (1.4 g, 0.011 mol) in toluene (2.0 g, 0.010 mol) and the mixture was reacted at 0 ° C for 3 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and the mixture was subjected to column separation (n-hexane: MC) to obtain 1.7 g (yield: 63%) of Intermediate 1-2 (m / z = 278)

(2) (2) 제조예Manufacturing example 2 : 중간체 1-3의 합성 2: Synthesis of intermediate 1-3

Figure 112014108723257-pat00042
Figure 112014108723257-pat00042

중간체 1-2(2.8 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol), DMF 100 mL를 넣고 20 ℃에서 8시간 교반하여 반응시켰다. 반응 종료 후 H20 : 아세트산에틸로 층분리 후 컬럼정제(n-Hexane:MC)하여 중간체 1-3을 1.8 g(41%)수득하였다.(m/z=436)
Bromine (3.2 g, 0.020 mol) and 100 mL of DMF were added to intermediate 1-2 (2.8 g, 0.010 mol), and the mixture was reacted at 20 ° C for 8 hours with stirring. After completion of the reaction H 2 0: column purification after separating layer with ethyl acetate: the intermediate 1-3 (n-Hexane MC) to afford 1.8 g (41%) (m / z = 436).

(3) (3) 제조예Manufacturing example 3 : 중간체 1-4의 합성 3: Synthesis of intermediate 1-4

Figure 112014108723257-pat00043
Figure 112014108723257-pat00043

4-tert-butylaniline(1.5 g, 0.010 mol)에 (3-bromophenyl)trimethylsilane (2.3 g, 0.010 mol), Pd(dba)2(0.5 g, 0.0005 mol), sodium-tert-butoxide(2.8 g, 0.030 mol)에 TOL 130 mL를 넣고 95 ℃에서 4시간 교반하여 반응시켰다. 반응종료 후 H20 : MC에 층분리 후 컬럼정제(n-HEXANE : MC)하여 중간체 1-4를 2.2 g(75%)수득하였다 (m/z=297)
(3-bromophenyl) trimethylsilane (2.3 g, 0.010 mol), Pd (dba) 2 (0.5 g, 0.0005 mol), sodium tert- mol), 130 mL of TOL was added, and the mixture was reacted at 95 DEG C for 4 hours with stirring. After completion of the reaction H 2 0: after separation layer MC column purification: yield (n-HEXANE MC) and 2.2 g (75%) of Intermediate 1-4 (m / z = 297)

(4) (4) 제조예Manufacturing example 4 : 화합물 1의 합성 4: Synthesis of compound 1

Figure 112014108723257-pat00044
Figure 112014108723257-pat00044

중간체 1-3(4.4 g, 0.010 mol)에 중간체 1-4(5.9 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 1> 6.2 g(수율 75%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3) to obtain Intermediate 1-4 (5.9 g, 0.020 mol) and Intermediate 1-3 (4.4 g, 0.010 mol) 75%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 6.51/d, 6.22/s, 2.34/s) 2H(8.34/s, 7.52/d, 7.51/m, 7.18/m, 7.01/d, 6.98/d, 6.68/d, 6.61/d, 6.56/d) 3H(6.55/d, 1.35/s) 4H(7.71/d) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 6.51 / d, 6.22 / s, 2.34 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 7.18 / m, 7.01 d, 6.98 d, 6.61 d, 6.56 d) 3H (6.55 / d, 1.35 / s) 4H (7.71 d)

LC/MS: m/z= 828[(M+1)+]
LC / MS: m / z = 828 [(M + 1) &lt; + &

실시예Example 2 : 화합물 2의 합성 2: Synthesis of Compound 2

(1) (One) 제조예Manufacturing example 1 : 중간체 2-1의 합성 1: Synthesis of intermediate 2-1

Figure 112014108723257-pat00045
Figure 112014108723257-pat00045

4-tert-butylaniline(1.5 g, 0.010 mol)에 bromobenzene(1.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 2-1> 1.7 g(수율 75%)을 얻었다.(m/z=225)
(1.7 g, 0.010 mol) was added to 4-tert-butylaniline (1.5 g, 0.010 mol) in the same manner as in Example 1- 75%). (M / z = 225)

(2) (2) 제조예Manufacturing example 2 : 중간체 2-2의 합성 2: Synthesis of intermediate 2-2

Figure 112014108723257-pat00046
Figure 112014108723257-pat00046

aniline(1.0 g, 0.010 mol)에 (4-bromo-3,5-dimethylphenyl)trimethylsilane (2.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 2-2> 1.9 g(수율 71%)을 얻었다.(m/z=269)
(2.6 g, 0.010 mol) was added to aniline (1.0 g, 0.010 mol) and 4-bromo-3,5-dimethylphenyltrimethylsilane (2.6 g, 0.010 mol) -2> 1.9 g (yield: 71%). (M / z = 269)

(3) (3) 제조예Manufacturing example 3 : 중간체 2-3의 합성 3: Synthesis of intermediate 2-3

Figure 112014108723257-pat00047
Figure 112014108723257-pat00047

중간체 1-3(4.4 g, 0.010 mol)에 중간체 2-1(2.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 2-3> 4.4 g(수율 75%)을 얻었다.(m/z=580)
Intermediate 2-1 (2.3 g, 0.010 mol) was added to Intermediate 1-3 (4.4 g, 0.010 mol) and the same procedure as in Example 1- (3) (Yield: 75%). (M / z = 580)

(4) (4) 제조예Manufacturing example 4 : 화합물 2의 합성 4: Synthesis of compound 2

Figure 112014108723257-pat00048
Figure 112014108723257-pat00048

중간체 2-3(5.8 g, 0.010 mol)에 중간체 2-2(2.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 2> 5.8 g(수율 75%)을 얻었다.The compound 2-2 (2.7 g, 0.010 mol) was added to Intermediate 2-3 (5.8 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (3) 75%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 6.22/s) 2H(8.34/d, 7.52/d, 7.51/m, 7.01/d, 6.86/s, 6.81/m, 6.55/d, 2.12/s) 3H(1.35/s, 0.25/s) 4H(7.71/d, 7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 6.22 / s) 2H (8.34 / d, 7.52 / d, 7.51 / m, 7.01 / d, 6.86 / s, 6.81 / m, 6.55 / d, 2.12 / s) 3H (1.35 / s, 0.25 / s) 4H (7.71 / d, 7.20 /

LC/MS: m/z=770 [(M+1)+]
LC / MS: m / z = 770 [(M + 1) &lt; + &

실시예Example 3 : 화합물 3의 합성 3: Synthesis of Compound 3

(1) (One) 제조예Manufacturing example 1 : 중간체 3-1의 합성 1: Synthesis of intermediate 3-1

Figure 112014108723257-pat00049
Figure 112014108723257-pat00049

aniline(1.0 g, 0.010 mol)에 1-bromo-3,5-di-tert-butylbenzene(2.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 3-1> 2.2 g(수율 78%)을 얻었다.(m/z=281)
was synthesized in the same manner as in Example 1 (3), except that 1-bromo-3,5-di-tert-butylbenzene (2.7 g, 0.010 mol) was added to aniline (1.0 g, 0.010 mol) 3-1> 2.2 g (yield 78%). (M / z = 281)

(2) (2) 제조예Manufacturing example 2 : 중간체 3-2의 합성 2: Synthesis of intermediate 3-2

Figure 112014108723257-pat00050
Figure 112014108723257-pat00050

aniline(1.0 g, 0.010 mol)에 (5-bromo-1,3-phenylene)bis(trimethylsilane) (3.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 3-2> 2.4 g(수율 78%)을 얻었다.(m/z=313)
was synthesized in the same manner as in Example 1 (3), except that 5-bromo-1,3-phenylene bis (trimethylsilane) (3.0 g, 0.010 mol) was added to aniline (1.0 g, 0.010 mol) 2.4 g (yield 78%) of Intermediate 3-2 (m / z = 313)

(3) (3) 제조예Manufacturing example 3 : 중간체 3-3의 합성 3: Synthesis of intermediate 3-3

Figure 112014108723257-pat00051
Figure 112014108723257-pat00051

중간체 1-3(4.4 g, 0.010 mol)에 중간체 3-2(3.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 3-3> 5.1 g(수율 77%)을 얻었다.(m/z=668)
Intermediate 3-2 (3.1 g, 0.010 mol) was added to Intermediate 1-3 (4.4 g, 0.010 mol) and the reaction was conducted in the same manner as in Example 1- (3) (Yield: 77%). (M / z = 668)

(4) (4) 제조예Manufacturing example 4 : 화합물 3의 합성 4: Synthesis of Compound 3

Figure 112014108723257-pat00052
Figure 112014108723257-pat00052

중간체 3-3(6.7 g, 0.010 mol)에 중간체 3-1(2.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 3> 6.2 g(수율 71%)을 얻었다.(m/z=456)Synthesis was conducted in the same manner as in Example 1-Preparation Example (3), except that Intermediate 3-1 (2.8 g, 0.010 mol) was added to Intermediate 3-3 (6.7 g, 0.010 mol) 71%). (M / z = 456)

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 7.06/s, 6.81/s, 6.22/s) 2H(8.34/s, 7.52/d, 7.51/m, 6.81/m, 6.66/s, 6.58/s) 4H(7.71/d, 7.20/m, 6.63/d) 6H(1.35/s, 0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 7.06 / s, 6.81 / s, 6.22 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 6.81 / m, 6.66 s, 6.58 / s) 4H (7.71 / d, 7.20 / m, 6.63 / d) 6H (1.35 / s, 0.25 / s)

LC/MS: m/z= 870[(M+1)+]
LC / MS: m / z = 870 [(M + 1) &lt; + &

실시예Example 4 : 화합물 4의 합성 4: Synthesis of compound 4

(1) (One) 제조예Manufacturing example 1 : 중간체 4-1의 합성 1: Synthesis of Intermediate 4-1

Figure 112014108723257-pat00053
Figure 112014108723257-pat00053

3,5-dimethylaniline(1.2 g, 0.010 mol)에 4-bromodibenzo[b,d]furan(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 4-1> 2.0 g(수율 70%)을 얻었다.(m/z=287)
(2.5 g, 0.010 mol) was added to 3,5-dimethylaniline (1.2 g, 0.010 mol) and 4-bromodibenzo [b, 4-1> 2.0 g (yield 70%). (M / z = 287)

(2) (2) 제조예Manufacturing example 2 : 화합물 4의 합성 2: Synthesis of Compound (4)

Figure 112014108723257-pat00054
Figure 112014108723257-pat00054

중간체 4-1(2.9 g, 0.010 mol)에 중간체 2-3(5.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 4> 6.1 g(수율 78%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3) to obtain Intermediate 4-1 (2.9 g, 0.010 mol) and Intermediate 2-3 (5.8 g, 0.010 mol) 78%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.89/d, 7.66/d, 7.41/m, 7.38/m, 7.32/m, 7.25/d, 7.07/d, 6.81/m, 6.71/s) 2H(8.34/d, 7.52/d, 7.51/m, 7.20/m, 7.01/d, 6.63/d, 6.55/d, 6.36/s, 2.34/s) 3H(1.35/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.89 / d, 7.66 / d, 7.41 / m, 7.38 / m, 7.32 / m, 7.25 / d, 7.07 / d, 6.81 / m, 6.71 / s ) 2H (8.34 / d, 7.52 / d, 7.51 / m, 7.20 / m, 7.01 / d, 6.63 / d, 6.55 / d, 6.36 / s, 2.34 / s) )

LC/MS: m/z=788 [(M+1)+]
LC / MS: m / z = 788 [(M + 1) &lt; + &

실시예Example 5 : 화합물 5의 합성 5: Synthesis of Compound 5

(1) (One) 제조예Manufacturing example 1 : 중간체 5-0의 합성 1: Synthesis of intermediate 5-0

Figure 112014108723257-pat00055
Figure 112014108723257-pat00055

aniline(1.0 g, 0.010 mol)에 (4-bromophenyl)trimethylsilane(2.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 5-0> 1.8 g(수율 76%)을 얻었다.(m/z=241)
<Synthesis of intermediate 5-0> (1.8 g, 0.010 mol) was prepared in the same manner as in Example 1 (3), except that (4-bromophenyl) trimethylsilane (2.3 g, 0.010 mol) Yield: 76%). (M / z = 241)

(2) (2) 제조예Manufacturing example 2 : 중간체 5-1의 합성 2: Synthesis of Intermediate 5-1

Figure 112014108723257-pat00056
Figure 112014108723257-pat00056

중간체 1-3(4.4 g, 0.010 mol)에 중간체 5-0(2.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 5-1> 4.5 g(수율 75%)을 얻었다.(m/z=596)
Intermediate 5-1 (4.5 g, 0.010 mol) was added to Intermediate 1-3 (4.4 g, 0.010 mol) and the reaction was conducted in the same manner as in Example 1- (3) (Yield: 75%). (M / z = 596)

(3) (3) 제조예Manufacturing example 3 : 화합물 5의 합성 3: Synthesis of Compound 5

Figure 112014108723257-pat00057
Figure 112014108723257-pat00057

중간체 5-1(6.0 g, 0.010 mol)에 중간체 4-1(2.9 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 5> 5.3 g(수율 66%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 4-1 (2.9 g, 0.010 mol) was added to Intermediate 5-1 (6.0 g, 0.010 mol) 66%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.89/d, 7.66/d, 7.41/m, 7.38/m, 7.32/m, 7.25/d, 7.07/m, 6.71/s, 6.39/d, 6.22/s) 2H(8.34/s, 7.52/d, 7.51/m, 7.20/m, 7.15/d, 6.63/d, 6.61/d, 6.36/s, 2.34/s) 3H(0.25/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.89 / d, 7.66 / d, 7.41 / m, 7.38 / m, 7.32 / m, 7.25 / d, 7.07 / m, 6.71 / s, 6.39 / d , 6.22 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 7.20 / m, 7.15 / d, 6.63 / (7.71 / d)

LC/MS: m/z=804 [(M+1)+]
LC / MS: m / z = 804 [(M + 1) &lt; + &

실시예Example 6 : 화합물 6의 합성 6: Synthesis of Compound 6

(1) (One) 제조예Manufacturing example 1 : 중간체 6-1의 합성 1: Synthesis of intermediate 6-1

Figure 112014108723257-pat00058
Figure 112014108723257-pat00058

3,5-dimethylaniline(1.2 g, 0.010 mol)에 4-bromodibenzo[b,d]thiophene (2.6 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 6-1> 2.3 g(수율 75%)을 얻었다.(m/z=303)
Synthesis was conducted in the same manner as in Example 1 (3), except that 4-bromodibenzo [b, d] thiophene (2.6 g, 0.010 mol) was added to 3,5-dimethylaniline (1.2 g, 0.010 mol) 6-1> 2.3 g (yield 75%) of the title compound (m / z = 303)

(2) (2) 제조예Manufacturing example 2 : 중간체 6-2의 합성 2: Synthesis of intermediate 6-2

Figure 112014108723257-pat00059
Figure 112014108723257-pat00059

중간체 6-1(3.0 g, 0.010 mol)에 중간체 1-3(4.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 6-2> 4.9 g(수율 75%)을 얻었다.(m/z=658)
Intermediate 6-1 was synthesized in the same manner as in Example 1- (3), except that Intermediate 6-1 (3.0 g, 0.010 mol) was added to Intermediate 1-3 (4.4 g, 0.010 mol) (Yield: 75%). (M / z = 658)

(3) (3) 제조예Manufacturing example 3 : 화합물 6의 합성 3: Synthesis of Compound 6

Figure 112014108723257-pat00060
Figure 112014108723257-pat00060

중간체 6-2(6.6 g, 0.010 mol)에 중간체 2-2(2.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 6> 6.1 g(수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (3) to obtain Intermediate 6-2 (6.6 g, 0.010 mol) and Intermediate 2-2 (2.7 g, 0.010 mol) 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 7.98/d, 7.81/d, 7.52/m, 7.50/m, 7.41/m, 7.27/m, 6.86/d, 6.81/m, 6.71/s, 6.36/s, 6.22/s) 2H(8.34/s, 7.52/d, 7.51/m, 7.20/m, 6.86/s, 6.63/d, 2.34/s, 2.12/s) 3H(0.25/s) 4H(7.71/d)M, 7.47 / m, 7.27 / m, 6.86 / d, 6.81 / m (1 H-NMR (200 MHz, CDCl 3 ) , 6.71 / s, 6.36 / s, 6.22 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 7.20 / / s) 4H (7.71 / d)

LC/MS: m/z= 848[(M+1)+]
LC / MS: m / z = 848 [(M + 1) &lt; + &

실시예Example 7 : 화합물 7의 합성 7: Synthesis of Compound 7

(1) (One) 제조예Manufacturing example 1 : 화합물 7의 합성 1: Synthesis of Compound 7

Figure 112014108723257-pat00061
Figure 112014108723257-pat00061

중간체 6-2(6.6 g, 0.010 mol)에 중간체 4-1(2.9 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 7> 6.6 g(수율 76%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 4-1 (2.9 g, 0.010 mol) was added to Intermediate 6-2 (6.6 g, 0.010 mol) 76%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 7.98/d, 7.89/d, 7.81/d, 7.52/m, 7.50/m, 7.41/m, 7.38/m, 7.32/m, 7.27/m, 7.25/d, 7.07/d, 6.36/d, 6.22/s) 2H(8.34/s, 7.52/d, 7.51/m, 6.71/s) 4H(7.71/d, 6.36/s, 2.34/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.45 / d, 7.98 / d, 7.89 / d, 7.81 / d, 7.52 / m, 7.50 / m, 7.41 / m, 7.38 / m, 7.32 / m , 7.27 / d, 7.07 / d, 6.36 / d, 6.22 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 6.71 / s) / s)

LC/MS: m/z= 866[(M+1)+]
LC / MS: m / z = 866 [(M + 1) &lt; + &

실시예Example 8 : 화합물 8의 합성 8: Synthesis of Compound 8

(1) (One) 제조예Manufacturing example 1 : 화합물 8의 합성 1: Synthesis of Compound 8

Figure 112014108723257-pat00062
Figure 112014108723257-pat00062

중간체 1-3(4.4 g, 0.010 mol)에 중간체 2-2(5.4 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 8> 5.8 g(수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 2-2 (5.4 g, 0.020 mol) was added to intermediate 1-3 (4.4 g, 0.010 mol) 71%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 6.22/s) 2H(8.34/s, 7.52/d, 7.51/m, 6.81/m) 4H(7.71/d, 7.20/m, 6.86/s, 6.63/d, 2.12/s) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 6.22 / s) 2H (8.34 / s, 7.52 / d, 7.51 / m, 6.81 / m) 4H (7.71 / d, 7.20 / m , 6.86 / s, 6.63 / d, 2.12 / s) 6H (0.25 / s)

LC/MS: m/z=814[(M+1)+]
LC / MS: m / z = 814 [(M + 1) &lt; + &

실시예Example 9 : 화합물 9의 합성 9: Synthesis of Compound 9

(1) (One) 제조예Manufacturing example 1 : 화합물 9의 합성 1: Synthesis of Compound (9)

Figure 112014108723257-pat00063
Figure 112014108723257-pat00063

중간체 1-3(4.4 g, 0.010 mol)에 중간체 4-1(5.7 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 9> 6.5 g(수율 77%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 4-1 (5.7 g, 0.020 mol) was added to intermediate 1-3 (4.4 g, 0.010 mol) 77%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 6.22/s) 2H(8.34/s, 7.89/d, 7.66/d, 7.52/d, 7.51/m, 7.38/m, 7.32/m, 7.25/d, 7.07/m, 6.71/s, 6.69/d) 4H(7.71/d, 6.36/s, 2.34/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 6.22 / s) 2H (8.34 / s, 7.89 / d, 7.66 / d, 7.52 / d, 7.51 / m, 7.38 / m, 7.32 6.71 / s, 6.69 / d) 4H (7.71 / d, 6.36 / s, 2.34 / s)

LC/MS: m/z=850[(M+1)+]
LC / MS: m / z = 850 [(M + 1) &lt; + &

실시예Example 10 : 화합물 10의 합성 10: Synthesis of Compound 10

(1) (One) 제조예Manufacturing example 1 : 중간체 10-1의 합성 1: Synthesis of intermediate 10-1

Figure 112014108723257-pat00064
Figure 112014108723257-pat00064

중간체 1-3(4.4 g, 0.010 mol)에 phenyl boronic acid(2.9 g, 0.024 mol), Pd(pph3)4(0.6 g, 0.0005 mol), potassium carbonate(2.8 g, 0.020 mol)에 THF 100 mL를 넣고 65 ℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane : MC)하여 <중간체 10-1>를 3.1 g(수율 72%)수득하였다.(m/z=430)
100 mL of THF was added to phenyl boronic acid (2.9 g, 0.024 mol), Pd (pph 3 ) 4 (0.6 g, 0.0005 mol) and potassium carbonate (2.8 g, 0.020 mol) And the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 3.1 g (yield 72%) of Intermediate 10-1 (m / z = 430)

(2) (2) 제조예Manufacturing example 2 : 중간체 10-2의 합성 2: Synthesis of intermediate 10-2

Figure 112014108723257-pat00065
Figure 112014108723257-pat00065

중간체 10-1(4.3 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 10-2> 1.9 g(수율 33%)을 얻었다.(m/z=588)
Intermediate 10-2 (1.9 g, Yield 33%) was obtained by synthesizing Intermediate 10-1 (4.3 g, 0.010 mol) with Bromine (3.2 g, 0.020 mol) %). (M / z = 588)

(3) (3) 제조예Manufacturing example 3 : 화합물 10의 합성 3: Synthesis of compound 10

Figure 112014108723257-pat00066
Figure 112014108723257-pat00066

중간체 10-2(5.9 g, 0.010 mol)에 diphenylamine(3.4 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 10> 6.2 g(수율 81%)을 얻었다.6.2 g (Yield: 81%) of Compound 10 was synthesized in the same manner as in Example 1- (3) except that diphenylamine (3.4 g, 0.020 mol) was added to Intermediate 10-2 (5.9 g, &Lt; / RTI >

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.26/s) 2H(8.34/d, 6.91/s) 3H(7.41/m) 4H(7.79/d, 6.81/m) 6H(7.51/m) 8H(7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.26 / s) 2H (8.34 / d, 6.91 / s) 3H (7.41 / m) 4H (7.79 / d, 6.81 / m) 6H (7.51 / m ) &Lt; / RTI &gt; 8H (7.20 / m, 6.63 / d)

LC/MS: m/z=765[(M+1)+]
LC / MS: m / z = 765 [(M + 1) &lt; + &

실시예Example 11 : 화합물 11의 합성 11: Synthesis of Compound 11

(1) (One) 제조예Manufacturing example 1 : 중간체 11-1의 합성 1: Synthesis of intermediate 11-1

Figure 112014108723257-pat00067
Figure 112014108723257-pat00067

중간체 1-3(4.4 g, 0.010 mol)에 중간체 4-1(2.9 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 11-1> 4.8 g(수율 75%)을 얻었다.(m/z=642)
Intermediate 4-1 (2.9 g, 0.010 mol) was added to Intermediate 1-3 (4.4 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (3) (Yield: 75%). (M / z = 642)

(2) (2) 제조예Manufacturing example 2 : 중간체 11-2의 합성 2: Synthesis of intermediate 11-2

Figure 112014108723257-pat00068
Figure 112014108723257-pat00068

4-tert-butylaniline(1.5 g, 0.010 mol)에 4-bromodibenzo[b,d]furan(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 11-2> 2.2 g(수율 70%)을 얻었다.(m/z=315)
(2.5 g, 0.010 mol) was added to 4-tert-butylaniline (1.5 g, 0.010 mol) and 4-bromodibenzo [b, 11-2> 2.2 g (yield 70%) (m / z = 315)

(3) (3) 제조예Manufacturing example 3 : 화합물 11의 합성 3: Synthesis of Compound 11

Figure 112014108723257-pat00069
Figure 112014108723257-pat00069

중간체 11-1(6.4 g, 0.010 mol)에 중간체 11-2(3.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 11> 6.6 g(수율 75%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 11-2 (3.2 g, 0.010 mol) was added to Intermediate 11-1 (6.4 g, 0.010 mol) 75%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/m, 6.71/s, 6.22/s) 2H(8.34/s, 7.89/d, 7.66/d, 7.52/d, 7.51/m, 7.38/m, 7.32/m, 7.25/d, 7.07/d, 7.01/d, 6.55/d, 6.39/d, 6.36/s, 2.34/s) 3H(1.35/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / m, 6.71 / s, 6.22 / s) 2H (8.34 / s, 7.89 / d, 7.66 / d, 7.52 / d, 7.51 / m, 7.38 d, 7.07 / d, 7.01 / d, 6.55 / d, 6.39 / d, 6.36 / s, 2.34 / s) 3H (1.35 / s)

LC/MS: m/z=878[(M+1)+]
LC / MS: m / z = 878 [(M + 1) &lt; + &

실시예Example 12 : 화합물 12의 합성 12: Synthesis of Compound 12

(1) (One) 제조예Manufacturing example 1 : 중간체 12-1의 합성 1: Synthesis of Intermediate 12-1

Figure 112014108723257-pat00070
Figure 112014108723257-pat00070

중간체 1-1(4.0 g, 0.012 mol)에 chlorohexane(1.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 12-1> 2.2 g(수율 77%)을 얻었다.(m/z=284)
Intermediate 12-1 (2.2 g, Yield 77%) was synthesized by the same method as in Example 1 (2), except that chlorohexane (1.2 g, 0.010 mol) was added to Intermediate 1-1 (4.0 g, 0.012 mol) %). (M / z = 284)

(2) (2) 제조예Manufacturing example 2 : 중간체 12-2의 합성 2: Synthesis of intermediate 12-2

Figure 112014108723257-pat00071
Figure 112014108723257-pat00071

중간체 12-1(2.8 g, 0.010 mol)에 N-bromosuccinimide(3.5 g, 0.020 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 12-2> 3.5 g(수율 60%)을 얻었다.(m/z=588)
3.5 g (0.020 mol) of N-bromosuccinimide was added to Intermediate 12-1 (2.8 g, 0.010 mol) and synthesized in the same manner as in Example 1 (1) Yield: 60%). (M / z = 588)

(3) (3) 제조예Manufacturing example 3 : 중간체 12-3의 합성 3: Synthesis of intermediate 12-3

Figure 112014108723257-pat00072
Figure 112014108723257-pat00072

중간체 12-2(5.9 g, 0.010 mol)에 중간체 2-2(2.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 12-3> 4.7 g(수율 75%)을 얻었다.(m/z=630)
<Intermediate 12-3> was synthesized in the same manner as in Example 1- (3), except that Intermediate 2-2 (2.7 g, 0.010 mol) was added to Intermediate 12-2 (5.9 g, 0.010 mol) (Yield: 75%). (M / z = 630)

(4) (4) 제조예Manufacturing example 4 : 화합물 12의 합성 4: Synthesis of Compound 12

Figure 112014108723257-pat00073
Figure 112014108723257-pat00073

중간체 12-3(6.3 g, 0.010 mol)에 diphenylamine(1.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 12> 5.0 g(수율 70%)을 얻었다.Compound (12) (5.0 g, yield 70%) was synthesized in the same manner as in Example 1 (3), except that diphenylamine (1.7 g, 0.010 mol) was added to Intermediate 12-3 (6.3 g, 0.010 mol) &Lt; / RTI >

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.81/m) 2H(7.99/d, 6.86/d, 6.81/m, 6.63/d, 2.12/s) 3H(0.25/s) 4H(7.71/d, 6.63/d) 6H(7.20/m) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.81 / m) 2H (7.99 / d, 6.86 / d, 6.81 / m, 6.63 / d, 2.12 / s) 3H (0.25 / s) 4H (7.71 / d, 6.63 / d) 6H (7.20 / m)

LC/MS: m/z=720[(M+1)+]
LC / MS: m / z = 720 [(M + 1) &lt; + &

실시예Example 13 : 화합물 13의 합성 13: Synthesis of compound 13

(1) (One) 제조예Manufacturing example 1 : 중간체 13-1의 합성 1: Synthesis of intermediate 13-1

Figure 112014108723257-pat00074
Figure 112014108723257-pat00074

중간체 12-2(4.4 g, 0.010 mol)에 중간체 4-1(2.9 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 13-1> 4.6 g(수율 71%)을 얻었다.(m/z=648)
Intermediate 4-1 (2.9 g, 0.010 mol) was added to Intermediate 12-2 (4.4 g, 0.010 mol) and the intermediate <13-1> was synthesized in the same manner as in Example 1- (Yield: 71%). (M / z = 648)

(2) (2) 제조예Manufacturing example 2 : 중간체 13-2의 합성 2: Synthesis of intermediate 13-2

Figure 112014108723257-pat00075
Figure 112014108723257-pat00075

1-chloro-3-fluorobenzene(1.3 g, 0.010 mol)에 p-toluidine(1.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 13-2> 1.5 g(수율 75%)을 얻었다.(m/z=201)
Intermediate 13-2 was synthesized by the same method as in Example 1 (3), except that p-toluidine (1.1 g, 0.010 mol) was added to 1-chloro-3-fluorobenzene (1.3 g, 0.010 mol) 1.5 g (yield 75%) of (m / z = 201)

(3) (3) 제조예Manufacturing example 3 : 화합물 13의 합성 3: Synthesis of Compound 13

Figure 112014108723257-pat00076
Figure 112014108723257-pat00076

중간체 13-1(6.5 g, 0.010 mol)에 중간체 13-2(2.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 13> 5.9 g(수율 77%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 13-2 (2.0 g, 0.010 mol) was added to Intermediate 13-1 (6.5 g, 0.010 mol) 77%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.89/d, 7.66/d, 7.38/m, 7.32/m, 7.25/d, 7.18/m, 7.07/d, 6.71/s, 6.60/d, 6.57/s, 6.40/d, 6.22/s) 2H(7.99/d, 6.98/d, 6.51/d, 6.36/s) 3H(2.34/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.89 / d, 7.66 / d, 7.38 / m, 7.32 / m, 7.25 / d, 7.18 / m, 7.07 / d, 6.71 / s, 6.60 / d , 6.57 / s, 6.40 / d, 6.22 / s) 2H (7.99 / d, 6.98 / d, 6.51 / d, 6.36 / s)

LC/MS: m/z=769[(M+1)+]
LC / MS: m / z = 769 [(M + 1) &lt; + &

실시예Example 14 : 화합물 14의 합성 14: Synthesis of compound 14

(1) (One) 제조예Manufacturing example 1 : 화합물 14의 합성 1: Synthesis of Compound 14

Figure 112014108723257-pat00077
Figure 112014108723257-pat00077

중간체 12-3(6.3 g, 0.010 mol)에 중간체 6-1(3.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 14> 5.9 g(수율 72%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 6-1 (3.0 g, 0.010 mol) was added to Intermediate 12-3 (6.3 g, 0.010 mol) 72%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.45/d, 7.98/d, 7.81/d, 7.52/m, 7.51/m, 7.07/d, 6.86/d, 6.22/s) 2H(7.99/d, 6.86/s, 6.81/m, 2.12/s) 3H(0.25/s) 4H(7.71/d, 7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.45 / d, 7.98 / d, 7.81 / d, 7.52 / m, 7.51 / m, 7.07 / d, 6.86 / d, 6.22 / s) 2H (7.99 d, 7.86 / s, 6.81 / m, 2.12 / s) 3H (0.25 /

LC/MS: m/z=826[(M+1)+]
LC / MS: m / z = 826 [(M + 1) &lt; + &

실시예Example 15 : 화합물 15의 합성 15: Synthesis of compound 15

(1) (One) 제조예Manufacturing example 1 : 중간체 15-1의 합성 1: Synthesis of intermediate 15-1

Figure 112014108723257-pat00078
Figure 112014108723257-pat00078

2-bromonaphthalene(2.1 g, 0.010 mol)에 aniline(1.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 15-1> 1.6 g(수율 72%)을 얻었다.(m/z=219)
1.6 g (Yield: 72%) of Intermediate 15-1 was synthesized in the same manner as in Example 1 (3) except that aniline (1.0 g, 0.010 mol) was added to 2-bromonaphthalene (2.1 g, ). (M / z = 219)

(2) (2) 제조예Manufacturing example 2 : 중간체 15-2의 합성 2: Synthesis of intermediate 15-2

Figure 112014108723257-pat00079
Figure 112014108723257-pat00079

1-bromonaphthalene(2.1 g, 0.010 mol)에 aniline(1.0 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 15-2> 1.6 g(수율 75%)을 얻었다.(m/z=219)
1.6 g (yield 75%) of Intermediate 15-2 was synthesized in the same manner as in Example 1 (3), except that aniline (1.0 g, 0.010 mol) was added to 1-bromonaphthalene (2.1 g, 0.010 mol) ). (M / z = 219)

(3) (3) 제조예Manufacturing example 3 : 중간체 15-3의 합성 3: Synthesis of intermediate 15-3

Figure 112014108723257-pat00080
Figure 112014108723257-pat00080

중간체 12-2(4.4 g, 0.010 mol)에 중간체 15-1(2.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 15-3> 3.8 g(수율 66%)을 얻었다.(m/z=580)
Intermediate 15-1 (2.2 g, 0.010 mol) was added to Intermediate 12-2 (4.4 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 1- (3) (Yield: 66%). (M / z = 580)

(4) (4) 제조예Manufacturing example 4 : 화합물 15의 합성 4: Synthesis of compound 15

Figure 112014108723257-pat00081
Figure 112014108723257-pat00081

중간체 15-3(5.8 g, 0.010 mol)에 중간체 15-2(2.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 15> 5.4 g(수율 75%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (3) to obtain Intermediate 15-3 (5.8 g, 0.010 mol) and Intermediate 15-2 (2.2 g, 0.010 mol) 75%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.07/d, 8.02/d, 7.88/d, 7.77/d, 7.74/s, 7.57/d, 7.54/m, 7.53/m, 7.50/m, 7.49/d, 7.38/m, 7.36/m, 6.98/d) 2H(7.99/d, 6.81/m) 4H(7.71/d, 7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.07 / d, 8.02 / d, 7.88 / d, 7.77 / d, 7.74 / s, 7.57 / d, 7.54 / m, 7.53 / m, 7.50 / m 7.99 / d, 6.81 / m) 4H (7.71 / d, 7.20 / m, 6.63 / d)

LC/MS: m/z= 719[(M+1)+]
LC / MS: m / z = 719 [(M + 1) &lt; + &

실시예Example 16 : 화합물 16의 합성 16: Synthesis of Compound 16

(1) (One) 제조예Manufacturing example 1 : 화합물 16의 합성 1: Synthesis of Compound (16)

Figure 112014108723257-pat00082
Figure 112014108723257-pat00082

중간체 12-2(4.4 g, 0.010 mol)에 중간체 3-2(6.3 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 16> 7.3 g(수율 80%)을 얻었다.Intermediate 3-2 (6.3 g, 0.020 mol) was added to Intermediate 12-2 (4.4 g, 0.010 mol) and the compound was obtained in the same manner as in Example 1- (3) 80%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.22/s) 2H(7.99/s, 7.06/s, 6.81/m) 4H(7.71/d, 7.20/m, 6.63/d, 6.56/s) 12H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.22 / s) 2H (7.99 / s, 7.06 / s, 6.81 / m) 4H (7.71 / d, 7.20 / m, 6.63 / d, 6.56 / s ) 12H (0.25 / s)

LC/MS: m/z=908[(M+1)+]
LC / MS: m / z = 908 [(M + 1) &lt; + &

실시예Example 17 : 화합물 17의 합성 17: Synthesis of Compound 17

(1) (One) 제조예Manufacturing example 1 : 중간체 17-1의 합성 1: Synthesis of intermediate 17-1

Figure 112014108723257-pat00083
Figure 112014108723257-pat00083

중간체 12-2(4.4 g, 0.010 mol)에 isopropylboronic acid(2.1 g, 0.024 mol)를 넣고 실시예 10-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 17-1> 2.6 g(수율 70%)을 얻었다.(m/z=368)
(2.1 g, 0.024 mol) was added to Intermediate 12-2 (4.4 g, 0.010 mol), and 2.6 g (yield: 2.6 g) of Intermediate 17-1 was obtained in the same manner as in Example 10 70%). (M / z = 368)

(2) (2) 제조예Manufacturing example 2 : 중간체 17-2의 합성 2: Synthesis of intermediate 17-2

Figure 112014108723257-pat00084
Figure 112014108723257-pat00084

중간체 17-1(3.7 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 17-2> 3.2 g(수율 61%)을 얻었다.(m/z=526)
(3.2 g, 0.020 mol) was added to Intermediate 17-1 (3.7 g, 0.010 mol), and 3.2 g (yield: 61%) of Intermediate 17-2 was synthesized in the same manner as in Example 1- %). (M / z = 526)

(3) (3) 제조예Manufacturing example 3 : 중간체 17-3의 합성 3: Synthesis of intermediate 17-3

Figure 112014108723257-pat00085
Figure 112014108723257-pat00085

4-(trimethylsilyl)aniline(1.7 g, 0.010 mol)에 4-bromodibenzo[b,d]furan (2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 17-3> 2.5 g(수율 75%)을 얻었다.(m/z=331)
Was synthesized in the same manner as in Example 1 (3), except that 4-bromodibenzo [b, d] furan (2.5 g, 0.010 mol) was added to 4- (trimethylsilyl) aniline (1.7 g, 0.010 mol) 2.5 g (yield 75%) of intermediate 17-3 was obtained. (M / z = 331)

(4) (4) 제조예Manufacturing example 4 : 화합물 17의 합성 4: Synthesis of Compound 17

Figure 112014108723257-pat00086
Figure 112014108723257-pat00086

중간체 17-2(5.3 g, 0.010 mol)에 중간체 17-3(3.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 17> 7.3 g(수율 71%)을 얻었다.The compound 17-3 (3.3 g, 0.010 mol) was added to Intermediate 17-2 (5.3 g, 0.010 mol) and the compound 17 was synthesized in the same manner as in Example 1- (3) 71%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.56/s) 2H(7.99/d, 7.89/d, 7.66/d, 7.38/m, 7.32/m, 7.25/d, 7.07/m, 6.91/s, 2.87/s) 4H(7.15/d, 6.61/d, 1.33/s) 6H(0.25/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.56 / s) 2H (7.99 / d, 7.89 / d, 7.66 / d, 7.38 / m, 7.32 / m, 7.25 / d, 7.07 / m, 6.91 / s, 2.87 / s) 4H (7.15 / d, 6.61 / d, 1.33 / s) 6H (0.25 / s)

LC/MS: m/z=1028[(M+1)+]
LC / MS: m / z = 1028 [(M + 1) &lt; + &

실시예Example 18 : 화합물 18의 합성 18: Synthesis of compound 18

(1) (One) 제조예Manufacturing example 1 : 화합물 18의 합성 1: Synthesis of compound 18

Figure 112014108723257-pat00087
Figure 112014108723257-pat00087

중간체 12-2(4.4 g, 0.010 mol)에 중간체 17-3(6.6 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 18> 5.8 g(수율 63%)을 얻었다.The compound 17-2 (6.6 g, 0.020 mol) was added to the intermediate 12-2 (4.4 g, 0.010 mol) and the compound 18 was synthesized in the same manner as in Example 1- (3) 63%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.22/s) 2H(7.99/d, 7.89/d, 7.66/d, 7.38/m, 7.32/m, 7.25/d, 7.15/d, 7.07/d, 7.01/d, 6.61/d, 6.55/d, 6.39/d) 3H(1.35/s, 0.25/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.22 / s) 2H (7.99 / d, 7.89 / d, 7.66 / d, 7.38 / m, 7.32 / m, 7.25 / d, 7.15 / d, 7.07 d, 7.01 / d, 6.61 / d, 6.55 / d, 6.39 / d) 3H (1.35 / s, 0.25 / s)

LC/MS: m/z=927 [(M+1)+]
LC / MS: m / z = 927 [(M + 1) &lt; + &

실시예Example 19 : 화합물 19의 합성 19: Synthesis of Compound 19

(1) (One) 제조예Manufacturing example 1 : 중간체 19-1의 합성 1: Synthesis of intermediate 19-1

Figure 112014108723257-pat00088
Figure 112014108723257-pat00088

pyrene(2.0 g, 0.010 mol)에 2-chloro-2-methylpropane(1.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 19-1> 1.7 g(수율 67%)을 얻었다.(m/z=258)
<Synthesis of Intermediate 19-1> 1.7 g (0.1 g) was obtained by synthesizing the same method as that of Example 1 (1) except that 2-chloro-2-methylpropane (1.1 g, 0.010 mol) (Yield: 67%). (M / z = 258)

(2) (2) 제조예Manufacturing example 2 : 중간체 19-2의 합성 2: Synthesis of intermediate 19-2

Figure 112014108723257-pat00089
Figure 112014108723257-pat00089

중간체 19-1(2.6 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 19-2> 3.1 g(수율 75%)을 얻었다.(m/z=416)
Intermediate 19-2 (3.1 g, yield 75%) was obtained by synthesizing the same method as that of Example 1- (3), with the exception that Bromine (3.2 g, 0.020 mol) was added to Intermediate 19-1 (2.6 g, 0.010 mol) %). (M / z = 416)

(3) (3) 제조예Manufacturing example 3 : 중간체 19-3의 합성 3: Synthesis of intermediate 19-3

Figure 112014108723257-pat00090
Figure 112014108723257-pat00090

중간체 19-2(4.2 g, 0.010 mol)에 isopropylboronic acid(2.1 g, 0.024 mol)를 넣고 실시예 10-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 19-3> 2.6 g(수율 77%)을 얻었다.(m/z=342)
Synthesis was conducted in the same manner as in Example 10- (1) except that isopropylboronic acid (2.1 g, 0.024 mol) was added to Intermediate 19-2 (4.2 g, 0.010 mol) 77%). (M / z = 342)

(4) (4) 제조예Manufacturing example 4 : 중간체 19-4의 합성 4: Synthesis of intermediate 19-4

Figure 112014108723257-pat00091
Figure 112014108723257-pat00091

중간체 19-3(3.4 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 19-4> 3.8 g(수율 75%)을 얻었다.(m/z=500)
(3.2 g, 0.020 mol) was added to Intermediate 19-3 (3.4 g, 0.010 mol), and 3.8 g (yield 75%) of Intermediate 19-4 was synthesized in the same manner as in Example 1- %). (M / z = 500)

(5) (5) 제조예Manufacturing example 5 : 화합물 19의 합성 5: Synthesis of Compound 19

Figure 112014108723257-pat00092
Figure 112014108723257-pat00092

중간체 19-4(5.0 g, 0.010 mol)에 diphenylamine(3.4 g, 0.020 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 19> 6.8 g(수율 75%)을 얻었다.6.8 g (Yield: 75%) of Compound 19 was synthesized in the same manner as in Example 1- (3) except that diphenylamine (3.4 g, 0.020 mol) was added to Intermediate 19-4 (5.0 g, &Lt; / RTI >

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.56/s) 2H(7.91/s, 6.91/s, 2.87/s) 3H(1.41/s) 4H(6.81/m, 1.33/s) 8H(7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.56 / s) 2H (7.91 / s, 6.91 / s, 2.87 / s) 3H (1.41 / s) 4H (6.81 / m, 1.33 / s) 8H (7.20 / m, 6.63 / d)

LC/MS: m/z=902[(M+1)+]
LC / MS: m / z = 902 [(M + 1) &lt; + &

실시예Example 20 : 화합물 20의 합성 20: Synthesis of Compound 20

(1) (One) 제조예Manufacturing example 1 : 중간체 20-1의 합성 1: Synthesis of intermediate 20-1

Figure 112014108723257-pat00093
Figure 112014108723257-pat00093

중간체 19-2(4.2 g, 0.010 mol)에 cyclohexylboronic acid(1.5 g, 0.012 mol)를 넣고 실시예 10-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 20-1> 2.8 g(수율 67%)을 얻었다.(m/z=422)
(1.5 g, 0.012 mol) was added to Intermediate 19-2 (4.2 g, 0.010 mol) and the compound was synthesized in the same manner as in Example 10-Preparation Example (1) to give 2.8 g 67%). (M / z = 422)

(2) (2) 제조예Manufacturing example 2 : 중간체 20-2의 합성 2: Synthesis of intermediate 20-2

Figure 112014108723257-pat00094
Figure 112014108723257-pat00094

중간체 20-1(4.3 g, 0.010 mol)에 Bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 20-2> 1.6 g(수율 28%)을 얻었다.(m/z=580)
Intermediate 20-2 (1.6 g, Yield 28%) was synthesized in the same manner as in Example 1- (2) except that Bromine (3.2 g, 0.020 mol) %). (M / z = 580)

(3) (3) 제조예Manufacturing example 3 : 화합물 20의 합성 3: Synthesis of Compound 20

Figure 112014108723257-pat00095
Figure 112014108723257-pat00095

중간체 20-2(4.4 g, 0.010 mol)에 중간체 5-0(2.4 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 20> 6.9 g(수율 77%)을 얻었다.Synthesis was conducted in the same manner as in Example 1 (3), except that Intermediate 5-0 (2.4 g, 0.010 mol) was added to Intermediate 20-2 (4.4 g, 0.010 mol) 77%).

H-NMR (200MHz, CDCl3):δ ppm, 2H(8.15/d, 6.91/s, 6.81/d) 3H(1.41/s) 4H(7.20/m, 7.15/d, 6.63/d, 6.61/d) 6H(0.25/s)(7.20 / m, 7.15 / d, 6.63 / d, 6.61 / d). &Lt; 1 &gt; H-NMR (200 MHz, CDCl3) ) 6H (0.25 / s)

LC/MS: m/z=902[(M+1)+]
LC / MS: m / z = 902 [(M + 1) &lt; + &

실시예Example 21 : 화합물 21의 합성 21: Synthesis of Compound 21

(1) (One) 제조예Manufacturing example 1 : 중간체 21-1의 합성 1: Synthesis of intermediate 21-1

Figure 112014108723257-pat00096
Figure 112014108723257-pat00096

중간체 19-2(4.2 g, 0.010 mol)에 중간체 17-3(3.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 21-1> 5.0 g(수율 75%)을 얻었다.(m/z=666)
Intermediate 21-1 was synthesized in the same manner as in Example 1- (3) except that Intermediate 17-3 (3.3 g, 0.010 mol) was added to Intermediate 19-2 (4.2 g, 0.010 mol) (Yield: 75%). (M / z = 666)

(2) (2) 제조예Manufacturing example 2 : 화합물 21의 합성 2: Synthesis of Compound 21

Figure 112014108723257-pat00097
Figure 112014108723257-pat00097

중간체 21-1(6.7 g, 0.010 mol)에 중간체 11-2(3.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 21> 7.0 g(수율 78%)을 얻었다.Synthesis was conducted in the same manner as in Example 1-Preparation Example (3), except that Intermediate 11-2 (3.2 g, 0.010 mol) was added to Intermediate 21-1 (6.7 g, 0.010 mol) 78%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(6.22/s) 2H(8.15/s, 7.89/d, 7.66/d, 7.38/m, 7.32/m, 7.25/d, 7.15/d, 7.07/d, 7.01/d, 6.61/d, 6.55/d, 6.39/d) 3H(1.41/s, 1.35/s, 0.25/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (6.22 / s) 2H (8.15 / s, 7.89 / d, 7.66 / d, 7.38 / m, 7.32 / m, 7.25 / d, 7.15 / d, 7.07 d, 7.01 / d, 6.61 / d, 6.55 / d, 6.39 / d) 3H (1.41 / s, 1.35 / s, 0.25 / s)

LC/MS: m/z=902[(M+1)+]
LC / MS: m / z = 902 [(M + 1) &lt; + &

실시예Example 22 : 화합물 22의 합성 22: Synthesis of Compound 22

(1) (One) 제조예Manufacturing example 1 : 중간체 22-1의 합성 1: Synthesis of Intermediate 22-1

Figure 112014108723257-pat00098
Figure 112014108723257-pat00098

pyrene(2.0 g, 0.010 mol)에 1-chloronaphthalene(1.9 g, 0.012 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 22-1> 3.9 g(수율 61%)을 얻었다.(m/z=328)
3.9 g (yield: 61%) of Intermediate 22-1 was synthesized in the same manner as in Example 1 (1) except that 1-chloronaphthalene (1.9 g, 0.012 mol) ). (M / z = 328)

(2) (2) 제조예Manufacturing example 2 : 중간체 22-2의 합성 2: Synthesis of Intermediate 22-2

Figure 112014108723257-pat00099
Figure 112014108723257-pat00099

중간체 10-1(4.3 g, 0.010 mol)에 bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 22-2> 2.3 g(수율 48%)을 얻었다.(m/z=486)
2.3 g (yield: 48%) of Intermediate 22-2 was synthesized in the same manner as in Example 1 (2) except that bromine (3.2 g, 0.020 mol) was added to Intermediate 10-1 (4.3 g, 0.010 mol) %). (M / z = 486)

(3) (3) 제조예Manufacturing example 3 : 중간체 22-3의 합성 3: Synthesis of intermediate 22-3

Figure 112014108723257-pat00100
Figure 112014108723257-pat00100

4-tert-butylaniline(1.5 g, 0.010 mol)에 4-bromobenzonitrile(1.8 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 22-3> 1.8 g(수율 70%)을 얻었다.(m/z=250)
Intermediate 22-3 was synthesized in the same manner as in Example 1 (3), except that 4-bromobenzonitrile (1.8 g, 0.010 mol) was added to 4-tert-butylaniline (1.5 g, 0.010 mol) (Yield: 70%). (M / z = 250)

(4) (4) 제조예Manufacturing example 4 : 중간체 22-4의 합성 4: Synthesis of intermediate 22-4

Figure 112014108723257-pat00101
Figure 112014108723257-pat00101

4-tert-butylaniline(1.5 g, 0.010 mol)에 4-chloro-3-fluorobiphenyl(2.1 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 22-4> 2.3 g(수율 73%)을 얻었다.(m/z=319)
Synthesis was conducted in the same manner as in Example 1 (3), except that 4-chloro-3-fluorobiphenyl (2.1 g, 0.010 mol) was added to 4-tert-butylaniline (1.5 g, 0.010 mol) 4> 2.3 g (yield: 73%). (M / z = 319)

(5) (5) 제조예Manufacturing example 5 : 중간체 22-5의 합성 5: Synthesis of intermediate 22-5

Figure 112014108723257-pat00102
Figure 112014108723257-pat00102

중간체 22-2(4.9 g, 0.010 mol)에 중간체 22-3(2.5 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 22-5> 4.9 g(수율 75%)을 얻었다.(m/z=655)
Intermediate 22-3 (2.5 g, 0.010 mol) was added to Intermediate 22-2 (4.9 g, 0.010 mol) and the intermediate <22-5> was synthesized in the same manner as in Example 1- (Yield: 75%). (M / z = 655)

(6) (6) 제조예Manufacturing example 6 : 화합물 22의 합성 6: Synthesis of Compound 22

Figure 112014108723257-pat00103
Figure 112014108723257-pat00103

중간체 22-5(6.6 g, 0.010 mol)에 중간체 22-4(3.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 22> 7.1 g(수율 79%)을 얻었다.The compound 22 was synthesized in the same manner as in Example 1 (3), except that Intermediate 22-4 (3.2 g, 0.010 mol) was added to Intermediate 22-5 (6.6 g, 0.010 mol) 79%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.55/d, 8.42/d, 8.08/d, 8.04/d, 7.61/m, 7.41/m, 7.31/d, 7.27/s, 6.22/s) 2H(8.34/s, 7.55/m, 7.52/d, 7.51/m, 7.39/d, 6.81/d) 4H(7.71/d, 7.01/d, 6.55/d) 6H(1.35/s) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.55 / d, 8.42 / d, 8.08 / d, 8.04 / d, 7.61 / m, 7.41 / m, 7.31 / d, 7.27 / s, 6.22 / s ) 2H (8.34 / s, 7.55 / m, 7.52 / d, 7.51 / m, 7.39 / d, 6.81 / d)

LC/MS: m/z= 895[(M+1)+]
LC / MS: m / z = 895 [(M + 1) &lt; + &

실시예Example 23 : 화합물 23의 합성 23: Synthesis of Compound 23

(1) (One) 제조예Manufacturing example 1 : 중간체 23-1의 합성 1: Synthesis of intermediate 23-1

Figure 112014108723257-pat00104
Figure 112014108723257-pat00104

pyrene(2.0 g, 0.010 mol)에 2-chloropyridine(1.4 g, 0.012 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 23-1> 1.7 g(수율 62%)을 얻었다.(m/z=279)
1.7 g (yield: 62%) of Intermediate 23-1 was synthesized in the same manner as in Example 1 (1) except that 2-chloropyridine (1.4 g, 0.012 mol) ). (M / z = 279)

(2) (2) 제조예Manufacturing example 2 : 중간체 23-2의 합성 2: Synthesis of intermediate 23-2

Figure 112014108723257-pat00105
Figure 112014108723257-pat00105

중간체 23-1(2.8 g, 0.010 mol)에 bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 23-2> 2.0 g(수율 45%)을 얻었다.(m/z=437)
2.0 g (yield: 45%) of Intermediate 23-2 (2.8 g, 0.010 mol) was synthesized in the same manner as in Example 1- (2) except that bromine (3.2 g, 0.020 mol) %). (M / z = 437)

(3) (3) 제조예Manufacturing example 3 : 중간체 23-3의 합성 3: Synthesis of intermediate 23-3

Figure 112014108723257-pat00106
Figure 112014108723257-pat00106

중간체 23-2(4.4 g, 0.010 mol)에 중간체 2-1(2.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 23-3> 4.4 g(수율 75%)을 얻었다.(m/z=581)
<Intermediate 23-3> 4.4 g (0.14 mmol) of Intermediate 23-2 was obtained by synthesizing Intermediate 2-1 (2.3 g, 0.010 mol) in the same manner as in Example 1- (3) (Yield: 75%). (M / z = 581)

(4) (4) 제조예Manufacturing example 4 : 화합물 23의 합성 4: Synthesis of Compound 23

Figure 112014108723257-pat00107
Figure 112014108723257-pat00107

중간체 23-3(5.8 g, 0.010 mol)에 중간체 2-2(2.7 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 23> 5.5 g(수율 71%)을 얻었다.Synthesis was conducted in the same manner as in Example 1- (3), except that Intermediate 2-2 (2.7 g, 0.010 mol) was added to Intermediate 23-3 (5.8 g, 0.010 mol) 71%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.85/s, 8.61/s, 8.50/d, 7.51/m, 7.26/d, 7.00/m, 6.22/s) 2H(7.01/d, 6.86/s, 6.81/m, 6.55/d, 2.12/s) 3H(1.35/s, 0.25/s) 4H(7.71/d, 7.20/m, 6.63/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.85 / s, 8.61 / s, 8.50 / d, 7.51 / m, 7.26 / d, 7.00 / m, 6.22 / s) 2H (7.01 / d, 6.86 s, 6.81 m, 6.55 d, 2.12 s) 3H (1.35 / s, 0.25 / s) 4H (7.71 / d, 7.20 /

LC/MS: m/z=771[(M+1)+]
LC / MS: m / z = 771 [(M + 1) &lt; + &

실시예Example 24 : 화합물 24의 합성 24: Synthesis of Compound 24

(1) (One) 제조예Manufacturing example 1 : 중간체 24-1의 합성 1: Synthesis of intermediate 24-1

Figure 112014108723257-pat00108
Figure 112014108723257-pat00108

pyrene(2.0 g, 0.010 mol)에 (E)-(2-chlorovinyl)benzene(1.7 g, 0.012 mol)를 넣고 실시예 1-제조예 (1)에서 사용된 동일한 방법으로 합성하여 <중간체 24-1> 2.0 g(수율 67%)을 얻었다.(m/z=304)
Synthesis was conducted in the same manner as in Example 1 (1) except that (E) - (2-chlorovinyl) benzene (1.7 g, 0.012 mol) was added to pyrene (2.0 g, 0.010 mol) > 2.0 g (yield 67%). (M / z = 304)

(2) (2) 제조예Manufacturing example 2 : 중간체 24-2의 합성 2: Synthesis of intermediate 24-2

Figure 112014108723257-pat00109
Figure 112014108723257-pat00109

중간체 24-1(3.0 g, 0.010 mol)에 bromine(3.2 g, 0.020 mol)를 넣고 실시예 1-제조예 (2)에서 사용된 동일한 방법으로 합성하여 <중간체 24-2> 1.7 g(수율 37%)을 얻었다.(m/z=462)
Intermediate 24-2 (1.7 g, Yield 37%) was synthesized in the same manner as in Example 1- (2) except that bromine (3.2 g, 0.020 mol) %). (M / z = 462)

(3) (3) 제조예Manufacturing example 3 : 중간체 24-3의 합성 3: Synthesis of intermediate 24-3

Figure 112014108723257-pat00110
Figure 112014108723257-pat00110

중간체 24-2(4.6 g, 0.010 mol)에 중간체 17-3(3.3 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <중간체 24-3> 5.3 g(수율 75%)을 얻었다.(m/z=712)
Intermediate 24-3 was synthesized in the same manner as in Example 1 (3), except that Intermediate 17-3 (3.3 g, 0.010 mol) was added to Intermediate 24-2 (4.6 g, 0.010 mol) (Yield: 75%). (M / z = 712)

(4) (4) 제조예Manufacturing example 4 : 화합물 24의 합성 4: Synthesis of Compound 24

Figure 112014108723257-pat00111
Figure 112014108723257-pat00111

중간체 24-3(7.1 g, 0.010 mol)에 N-(4-tert-butylphenyl)dibenzo[b,d] furan-4-amine(3.2 g, 0.010 mol)를 넣고 실시예 1-제조예 (3)에서 사용된 동일한 방법으로 합성하여 <화합물 24> 6.9 g(수율 75%)을 얻었다.(3) was prepared by adding N- (4-tert-butylphenyl) dibenzo [b, d] furan-4-amine (3.2 g, 0.010 mol) to Intermediate 24-3 (7.1 g, 0.010 mol) (Compound 24) (6.9 g, yield 75%).

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.28/s, 8.04/s, 7.30/m, 6.71/s, 6.22/s) 2H(7.89/d, 7.72/d, 7.66/d, 7.45/m, 7.38/m, 7.28/m, 7.25/d, 7.15/d, 7.07/m, 6.95/s, 6.61/d, 6.39/d, 6.36/s, 2.34/s) 3H(0.25/s) 4H(7.71/d) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.28 / s, 8.04 / s, 7.30 / m, 6.71 / s, 6.22 / s) 2H (7.89 / d, 7.72 / d, 7.66 / d, 7.45 s), 3H (0.25 / s), 4H (m / z, 7.38 / m, 7.28 / m, 7.25 / d, 7.15 / d, 7.07 / m, 6.95 / s, 6.61 / d, 6.39 / d, 6.36 / s, (7.71 / d)

LC/MS: m/z=920[(M+1)+]
LC / MS: m / z = 920 [(M + 1) &lt; + &

소자 device 실시예Example 1 : 화합물 1을  1: Compound 1 발광층의The light- 형광블루도펀트Fluorescent blue dopant 재료로 하여  As a material 유기전계Organic field 발광소자 제조Light emitting device manufacturing

ITO로 코팅된 유리기판 위에 CuPc를 80 nm, α-NPD를 30 nm를 성막한 후 <화합물 A> + <화합물 1> 6%를 혼합하여 25 nm, 증착속도 0.1 m/sec로 성막한 다음 Alq3를 40 nm, LiF을 1 nm, Al을 120 nm의 순서로 성막하여 유기전계발광소자를 제조하였다. 이때, 각 물질의 증착속도는 CuPc, α-NPD, Alq3는 0.1 nm/sec, LiF는 0.01 nm/sec, Al은 0.5 nm/sec로 하였다.
After depositing 80 nm of CuPc and 30 nm of α-NPD on a glass substrate coated with ITO, the film was formed at 25 nm with a deposition rate of 0.1 m / sec by mixing <Compound A> + <Compound 1> 6% 3 was deposited to 40 nm, LiF was deposited to 1 nm, and Al was deposited to 120 nm in this order. Thus, an organic electroluminescent device was manufactured. At this time, deposition rates of CuPc, α-NPD, Alq 3 , LiF and Al were 0.5 nm / sec, 0.1 nm / sec, 0.01 nm / sec and 0.5 nm / sec, respectively.

소자 device 실시예Example 2 내지 24 2 to 24

상기 화합물 2 대신 하기 [표 1]에 기재된 화합물을 사용한 것을 제외하고는 소자 실시예 1과 동일한 방법으로 소자 실시예 2 내지 24의 유기전계발광소자를 제조하였다.
An organic electroluminescent device of each of the device embodiments 2 to 24 was fabricated in the same manner as in the device example 1, except that the compound described in [Table 1] was used instead of the compound 2.

소자 device 비교예Comparative Example 1 One

비교예를 위한 유기발광다이오드 소자는 상기 실시예의 소자구조에서 발명에 의해 제조된 화합물 대신 일반적으로 형광 도펀트 물질로 많이 사용되고 있는 화합물B를 사용한 점을 제외하고 동일하게 제작하였으며, 상기 화합물 A, 화합물 B의 구조는 다음과 같다.The organic light emitting diode device for the comparative example was fabricated in the same manner except that the compound B, which is generally used as a fluorescent dopant material instead of the compound prepared by the invention in the device structure of the embodiment, was used. The structure of

Figure 112014108723257-pat00112

Figure 112014108723257-pat00112

이하, 상기 소자 실시예 1 내지 24와 소자 비교예 1에 따라 제조된 유기전계발광소자의 특성을 비교한 결과를 하기 [표 1]에 나타내었다.The results of comparing the characteristics of the organic electroluminescent devices manufactured according to the device embodiments 1 to 24 and the device comparative example 1 are shown in Table 1 below.

[표 1][Table 1]

Figure 112014108723257-pat00113

Figure 112014108723257-pat00113

구동전압 및 발광효율 측정Measurement of driving voltage and luminous efficiency

상기 실시예 및 비교예에 따른 유기전계발광소자(기판크기 : 25 × 25 ㎟ / 증착면적 : 2 × 2 ㎟)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정한 후 전류를 1 mA/㎡씩 상승시키며 증착면의 발광 휘도(cd/㎡), 구동전압(V), 발광효율(cd/A)을 측정하여 상기 [표 1]에 나타내었다. 상기 실시예 와 비교예 및 [표 1]의 결과로부터, 본 발명에 따른 화학식 1 내지 24로 표시되는 화합물은 종래의 청색형광 도펀트를 사용한 경우보다 구동전압 및 발광효율 등의 특성이 우수함을 보이므로, 표시소자, 디스플레이 소자 및 조명 등에 유용하게 사용될 수 있음을 알 수 있다.After fixing the organic electroluminescent device (substrate size: 25 × 25 mm 2 / deposition area: 2 × 2 mm 2) according to the above Examples and Comparative Examples to an IVL measurement set (CS-2000 + jig + IVL program) (Cd / m &lt; 2 &gt;), driving voltage (V) and luminous efficiency (cd / A) of the deposition surface were measured. From the results of the above Examples, Comparative Examples and Table 1, the compounds represented by the general formulas (1) to (24) according to the present invention show excellent characteristics such as driving voltage and luminous efficiency as compared with the case of using the conventional blue fluorescent dopant , A display element, a display element, an illumination, and the like.

Claims (11)

하기 [화학식 1]로 표시되는 유기발광 화합물:
[화학식 1]
Figure 112017116758325-pat00159

상기 [화학식 1]에서,
A1 및 A2는 각각 독립적으로 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 치환 또는 비치환된 탄소수 3 내지 20의 시클로알킬기 및 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 중에서 선택되고,
R1 및 R2는 각각 하기 [구조식 1]로 표시되는 아민기이며,
[구조식 1]
Figure 112017116758325-pat00160

상기 [구조식 1]에서,
Ar1 및 Ar2는 각각 독립적으로 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 및 치환 또는 비치환된 탄소수 3 내지 24의 헤테로아릴기 중에서 선택되고,
L은 직접 결합이며 (n은 1이다.),
R은 치환 또는 비치환된 탄소수 1 내지 10의 알킬기, 치환 또는 비치환된 탄소수 3 내지 20의 시클로알킬기 및 치환 또는 비치환된 탄소수 6 내지 20의 아릴기 중에서 선택되고,
A1, A2, Ar1, Ar2 및 R이 각각 독립적으로 1종 이상의 치환기로 더 치환되는 경우, 상기 1종 이상의 치환기는 시아노기, 할로겐기, 탄소수 1 내지 10의 알킬기, 탄소수 1 내지 10의 알킬실릴기, 탄소수 1 내기 10의 알콕시기, 탄소수 6 내지 20의 아릴기 및 탄소수 3 내지 24의 헤테로아릴기 중에서 선택된다.
An organic light-emitting compound represented by the following Formula 1:
[Chemical Formula 1]
Figure 112017116758325-pat00159

In the above formula (1)
A 1 and A 2 are each independently selected from a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 carbon atoms and a substituted or unsubstituted aryl group having 6 to 20 carbon atoms,
R 1 and R 2 are each an amine group represented by the following structural formula 1,
[Structural formula 1]
Figure 112017116758325-pat00160

In the above formula 1,
Ar 1 and Ar 2 are each independently selected from a substituted or unsubstituted aryl group having 6 to 20 carbon atoms and a substituted or unsubstituted heteroaryl group having 3 to 24 carbon atoms,
L is a direct bond (n is 1),
R is selected from a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms, a substituted or unsubstituted cycloalkyl group having 3 to 20 carbon atoms, and a substituted or unsubstituted aryl group having 6 to 20 carbon atoms,
When at least one of A 1 , A 2 , Ar 1 , Ar 2 and R is independently substituted with at least one substituent, the at least one substituent is a cyano group, a halogen group, an alkyl group having 1 to 10 carbon atoms, An alkylsilyl group of 1 to 10 carbon atoms, an alkoxy group of 1 to 10 carbon atoms, an aryl group of 6 to 20 carbon atoms, and a heteroaryl group of 3 to 24 carbon atoms.
삭제delete 삭제delete 삭제delete 삭제delete 제1 전극, 제2 전극, 및 상기 제1 전극과 제2 전극 사이에 배치된 1층 이상의 유기물층을 포함하는 유기전계발광소자로서,
상기 유기물층 중 1 층 이상은 제1항에 따른 [화학식 1]의 유기발광 화합물을 포함하는 것인 유기전계발광소자.
1. An organic electroluminescent device comprising a first electrode, a second electrode, and at least one organic material layer disposed between the first electrode and the second electrode,
Wherein at least one of the organic material layers comprises an organic light emitting compound represented by Formula 1 according to Claim 1.
제6항에 있어서,
상기 유기물층은 정공 주입층, 정공 수송층, 정공 주입 및 정공 수송을 동시에 하는 층, 전자 수송층, 전자 주입층, 전자 수송 및 전자 주입을 동시에 하는 층 및 발광층 중 1층 이상을 포함하고,
상기 층들 중 1층 이상이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
The method according to claim 6,
Wherein the organic material layer includes at least one of a hole injecting layer, a hole transporting layer, a layer simultaneously transporting holes and holes, an electron transporting layer, an electron injecting layer, a layer that simultaneously transports electrons and electrons,
Wherein at least one of the layers comprises an organic light-emitting compound represented by the formula (1).
제7항에 있어서,
상기 발광층이 상기 [화학식 1]로 표시되는 유기발광 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자.
8. The method of claim 7,
Wherein the light emitting layer comprises an organic light emitting compound represented by the following formula (1).
제7항에 있어서,
상기 [화학식 1]로 표시되는 유기발광 화합물은 상기 발광층 내의 도판트 화합물로 사용되는 것을 특징으로 하는 유기전계발광소자.
8. The method of claim 7,
Wherein the organic light emitting compound represented by Formula 1 is used as a dopant compound in the light emitting layer.
제8항에 있어서,
상기 발광층은 [화학식 1]로 표시되는 유기발광 화합물 외의 호스트 화합물 화합물을 1종 이상 더 포함하는 것을 특징으로 하는 유기전계발광소자.
9. The method of claim 8,
Wherein the light emitting layer further comprises at least one host compound compound other than the organic light emitting compound represented by Formula 1. &lt; EMI ID = 1.0 &gt;
삭제delete
KR1020140156829A 2014-11-12 2014-11-12 An electroluminescent compound and an electroluminescent device comprising the same KR101837049B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020140156829A KR101837049B1 (en) 2014-11-12 2014-11-12 An electroluminescent compound and an electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020140156829A KR101837049B1 (en) 2014-11-12 2014-11-12 An electroluminescent compound and an electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20160056522A KR20160056522A (en) 2016-05-20
KR101837049B1 true KR101837049B1 (en) 2018-03-09

Family

ID=56103681

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020140156829A KR101837049B1 (en) 2014-11-12 2014-11-12 An electroluminescent compound and an electroluminescent device comprising the same

Country Status (1)

Country Link
KR (1) KR101837049B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11437581B2 (en) * 2019-05-24 2022-09-06 Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. Blue fluorescent material and display panel

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111333483B (en) * 2020-03-13 2024-01-26 陕西师范大学 Pyrene blue organic fluorescent material and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013063930A (en) 2011-09-16 2013-04-11 Idemitsu Kosan Co Ltd Aromatic amine derivative, and organic electroluminescent element using the same
JP2014506232A (en) * 2010-10-15 2014-03-13 メルク パテント ゲーエムベーハー Compounds for electronic devices

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014506232A (en) * 2010-10-15 2014-03-13 メルク パテント ゲーエムベーハー Compounds for electronic devices
JP2013063930A (en) 2011-09-16 2013-04-11 Idemitsu Kosan Co Ltd Aromatic amine derivative, and organic electroluminescent element using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11437581B2 (en) * 2019-05-24 2022-09-06 Wuhan China Star Optoelectronics Semiconductor Display Technology Co., Ltd. Blue fluorescent material and display panel

Also Published As

Publication number Publication date
KR20160056522A (en) 2016-05-20

Similar Documents

Publication Publication Date Title
KR101825405B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101852926B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101530266B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627691B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20170082459A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101842013B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101837048B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101790550B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101626524B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160127429A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160066308A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160054870A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627695B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101666826B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20150110101A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101713530B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20150133097A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20160006007A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101638073B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20180042944A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627693B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101627689B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101816810B1 (en) An electroluminescent compound and an electroluminescent device comprising the same
KR20180042967A (en) An electroluminescent compound and an electroluminescent device comprising the same
KR101640478B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant